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Introduction 
 
      Reports of tuberculosis (TB) cases are submitted to the Division of TB Elimination (DTBE), 
Centers for Disease Control and Prevention (CDC), by 60 reporting areas (the 50 states, the 
District of Columbia, New York City, Puerto Rico, and other jurisdictions in the Pacific and 
Caribbean).  In January 1993, DTBE, in conjunction with state and local health departments, 
implemented an expanded TB surveillance system.  The expanded system collects additional 
information for each reported TB case in order to better monitor trends in TB, including drug-
resistant TB, in the United States.  A software package (SURVS-TB) for data entry, analysis, 
and transmission of case reports to CDC was designed and implemented as part of the expanded 
TB surveillance system.  In 1998, the Tuberculosis Information Management System (TIMS) 
replaced SURVS-TB in order to provide reporting areas with a comprehensive software for 
surveillance, patient management, and program evaluation.  
      This publication, Reported Tuberculosis in the United States, 2000, presents summary data 
for TB cases reported to DTBE during 2000.  It is similar to previous publications (page 5, #19) 
and contains six major sections.  The first section presents trends in the overall TB case counts 
and case rates by selected demographic and clinical characteristics.  In addition to Table 1, 
which presents data from 1953 to the present, Tables 2 through 6 present data for the past 11 
years, and Tables 7 through 10 present data collected since implementation of the expanded 
system in 1993, including drug resistance and clinical outcomes.  
      The second section (Tables 11 through 14) presents overall case counts and rates by selected 
demographic characteristics for 2000.  In the third section, TB case counts and case rates are 
presented by state with tables of selected demographic and clinical characteristics.  In the fourth 
section, data collected as part of the expanded system (e.g., initial drug resistance, HIV status) 
are presented by reporting area.  The fifth section provides TB case counts and case rates by 
metropolitan statistical areas (MSAs: see Technical Notes, Appendix A, for further details) with 
tables of selected demographic and clinical characteristics.  Finally, the sixth section, presents 
figures from the annual surveillance slide set, which emphasize key recent trends in TB 
epidemiology in the United States.  The slides with accompanying text can also be viewed and 
downloaded from the Division Home Page which is accessible via the Internet: 
www.cdc.gov/nchstp/tb. 
      To help interpret the data, an Executive Commentary (page 2) and Technical Notes 
(Appendix A) have been included.  In addition, the current case definition (MMWR 1997;46 [No. 
RR-10]:40-1) and “Recommendations for Counting Reported Tuberculosis Cases” are provided 
in Appendices B and C, respectively.  The recommendations for counting TB cases, which 
update the January 1977 recommendations, were first published in Reported Tuberculosis in the 
United States, 1996.   
      We will continue to adapt and improve this publication to better monitor trends in TB in the 
United States.  Your comments and suggestions that may assist us in this process will be greatly 
appreciated.  
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Executive Commentary     
   
      During 2000, a total of 16,377 TB cases (5.8 cases per 100,000 population) were reported to 
CDC from the 50 states and the District of Columbia, representing a 7% decrease from 1999 and 
a 39% decrease from 1992, when the number of cases peaked during the resurgence of TB in the 
United States.  The national TB case rate also steadily decreased during this period (Table 1).  In 
2000, 6% of cases were reported in children under 15 years old, 10% in persons aged 15-24 
years, 34% in persons aged 25-44 years, 28% in persons aged 45-64 years, and 22% in persons 
aged 65 years and older (Table 2).  During 1992-2000, there was a decline in both the number of 
cases reported in each of these age groups and the respective TB case rates. 
       The overall national trends reflect the impact of varying changes within population 
subgroups.  For example, the overall decrease in TB cases during 1992-2000 primarily reflects a 
55% decrease in the number of cases among U.S.-born persons, with substantial declines in all 
age groups.  In contrast, the total number of cases among foreign-born persons increased 4% 
during this period, reflecting small to moderate increases in adult age groups, but a substantial 
decline among children aged <15 years.  In terms of case rates, the case rate among U.S.-born 
persons decreased from 8.2 to 3.5 per 100,000 population, and the case rate among foreign-born 
persons decreased from 34.2 to 25.8 per 100,000 population (Table 4).  [Note: The case rates in 
Table 4 were calculated using two U.S. Census sources: one for 1992-1999 rates and one applied 
to the April 2000 Census total U.S. population for the 2000 rate.  Thus, the 1992 and 2000 
estimates may not be directly comparable.  Using the first source, the case rate in the foreign-
born decreased from 34.2 to 29.2 per 100,000 (15%) between 1992 and 1999.]    
       The overall trends also reflect the impact of changes by geographic location.  For example, 
during 1992-2000, the seven states with the highest number of cases (California, Florida, Georgia, 
Illinois, New Jersey, New York, and Texas, accounting for 59% of the total number of U.S. cases 
in 2000) experienced a substantial decrease in both annual number of reported cases and case 
rate.  Overall decreases also occurred in 17 other states and the District of Columbia during the 9-
year period.  In the remaining 26 states, annual case counts fluctuated (e.g., increased, then 
decreased) or remained relatively stable during 1992-2000.  Eighteen of these states had case 
rates ≤3.5 per 100,000 (16 states) or reported less than 100 cases (16 states) in 2000.  
       The resurgence of TB in the United States in the late 1980s and early 1990s was associated 
with the emergence of multidrug-resistant TB (MDR TB) and the HIV/AIDS epidemic.1,2  Based 
on initial drug susceptibility test results for Mycobacteruim tuberculosis isolates from persons 
with culture-positive TB, resistance to at least isoniazid during 1993-2000 was relatively stable 
and MDR TB decreased substantially.  In 2000, 8% of isolates were resistant to at least isoniazid 
and 1% were resistant to at least isoniazid and rifampin (MDR TB) (Table 30).  The decrease in 
the level of MDR TB was largely influenced by the decrease in New York City; however, during 
1993-2000, the proportion of TB cases reported from U.S. areas excluding New York City that 
were MDR TB decreased from 1.7% to 1%.  Trends in primary resistance, based on results for 
isolates from persons with no prior history of TB, were similar (Table 7).   
       Incomplete reporting has limited the analysis of national TB surveillance data by HIV status. 
 Reporting of HIV status has improved slowly since 1993, the year such information was first 
included on TB case reports submitted to CDC.  In 2000, 58% of TB case reports for persons 
aged 25-44 years included information about HIV status.  Nineteen states and the District of 
Columbia reported this information for at least 75% of cases among persons in this age group 
(Table 31).   To help estimate the proportion of reported TB cases with HIV coinfection, state 
health departments have compared TB and AIDS registries.3  Using registry matched data to 
supplement HIV test results reported on the individual TB case report, minimum estimates of the 
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proportion with HIV coinfection range from 15% in 1993-1994 to 10% in 1998-1999 for persons 
of all ages reported with TB and from 29% in 1993-1994 to 19% in 1999 for persons aged 25-44 
(Table 10).  The impact of the HIV/AIDS epidemic also differs by geographic location.  For 
example, in 2000, over one-quarter of TB cases in persons aged 25-44 years from the District of 
Columbia, Florida, Georgia, North Carolina, and South Carolina were coinfected with HIV, 
whereas (among states with more than 5 cases in this age group), <10% of cases from Kansas, 
Minnesota, Oklahoma, Oregon, and Wisconsin were reported with HIV coinfection.  
       During 1992-2000, the declines in the overall number of reported TB cases and in the level of 
MDR TB appear to reflect successful efforts to strengthen TB control following the resurgence of 
TB and the emergence of MDR TB.  Activities emphasizing the first priority of TB control4 (i.e., 
promptly identifying persons with TB, initiating appropriate therapy, and ensuring completion of 
therapy) have likely been the most important factors in achieving this improvement.  Such 
activities reduced community transmission of M. tuberculosis, particularly in areas with a high 
incidence of AIDS.5   Improvements in infection control practices in nosocomial and other 
congregate settings, declining AIDS incidence, and the decreasing number of MDR TB cases also 
appear to have contributed to the overall decrease; however, the contribution of these factors has 
been difficult to measure.  The substantial decline in both the number of reported cases among 
U.S.-born persons and the case rate for U.S.-born persons supports these inferences.  In 
comparison, the relatively stable number of reported cases among foreign-born persons, along 
with the modest decline in the case rate among foreign-born persons (supported by examination 
of case rates during 1992-1999 using the same method and source for estimating foreign-born 
populations), is consistent with other analyses of TB surveillance data that indicate that most 
cases of TB among foreign-born U.S. residents result from infection with M. tuberculosis in the 
person’s country of birth.6  As the proportion of reported TB cases among foreign-born persons 
continues to increase, the elimination of TB in the United States will depend increasingly on the 
elimination of TB among foreign-born persons.7,8  CDC, in collaboration with state and local 
health departments, has published recommendations for enhancing TB control efforts in the 
foreign-born,7,9 and is currently working with these jurisdictions to expand efforts based on these 
recommendations.   
       To move from TB control to TB elimination in the United States, the Advisory Council for 
the Elimination of Tuberculosis (ACET) has emphasized that existing efforts must be sustained 
and enhanced.10  The recent report from the Institute of Medicine, Ending Neglect: The 
Elimination of Tuberculosis in the United States, affirms ACET’s recommendation and also poses 
the important question that now confronts the nation, “whether another cycle of neglect will be 
allowed to begin, or whether, instead, decisive action will be taken to eliminate the disease.”11  
The expanded national TB surveillance system has proven its usefulness in assisting in the 
evaluation of the success of TB control efforts and monitoring the status of the epidemic, 
particularly through the collection of data on initial drug susceptibility results.12  Information on 
the use of initial regimens of four first-line drugs, directly observed therapy, and completion of 
therapy in 1 year or less (Table 9) can also be used as measures to evaluate program success.  As 
future efforts towards TB elimination increase, both existing and new surveillance systems at the 
national, state, and local levels will become ever more critical to monitor the burden and impact 
of TB, evaluate the success of control and prevention efforts, and direct planning and policy 
development. 
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Table 1. Tuberculosis Cases and Case Rates per 100,000 Population,  
Deaths and Death Rates per 100,000 Population: United States, 1953-2000
Tuberculosis Cases Tuberculosis Deaths
Percent Change Percent Change
Year Number Rate 1 Number Rate Number Rate 1  Number Rate
1953  84,304 53.0 - - - - 19,707 12.4 - - - -
1954 79,775 49.3 -5.4 - 7.0 16,527 10.2 -16.1 -17.7
1955 77,368 46.9 -3.0 - 4.9 15,016 9.1 - 9.1 -10.8
1956 69,895 41.6 -9.7 -11.0 14,137 8.4 - 5.9 - 7.7
1957 67,149 39.2 -3.9 - 5.8 13,390 7.8 - 5.3 - 7.1
1958 63,534 36.5 -5.4 - 6.9 12,417 7.1 - 7.3 - 9.0
1959 57,535 32.5 -9.4 -11.0 11,474 6.5 - 7.6 - 8.5
1960 55,494 30.8 -3.5 - 5.2 10,866 6.0 - 5.3 - 7.7
1961 53,726 29.4 -3.2 - 4.5 9,938 5.4 - 8.5 -10.0
1962 53,315 28.7 -0.8 - 2.4 9,506 5.1 - 4.3 - 5.6
1963 54,042 28.7 +1.4 0.0 9,311 4.9 - 2.1 - 3.9
1964 50,874 26.6 -5.9 - 7.3 8,303 4.3 -10.8 -12.2
1965 49,016 25.3 -3.7 - 4.9 7,934 4.1 - 4.4 - 4.7
1966 47,767 24.4 -2.5 - 3.6 7,625 3.9 - 3.9 - 4.9
1967 45,647 23.1 -4.4 - 5.3 6,901 3.5 - 9.5 -10.3
1968 42,623 21.3 -6.6 - 7.8 6,292 3.1 - 8.8 -11.4
1969 39,120 19.4 -8.2 - 8.9 5,567 2.8 -11.5 - 9.7
1970 37,137 18.3 -5.1 - 5.7 5,217 2.6 - 6.3 - 7.1
1971 35,217 17.1 -5.2 - 6.6 4,501 2.2 -13.7 -15.4
1972 32,882 15.8 -6.6 - 7.6 4,376 2.1 - 2.8 - 4.5
1973 30,998 14.8 -5.7 - 6.3 3,875 1.8 -11.4 -14.5
1974 30,122 14.2 -2.8 - 4.1 3,513 1.7 - 9.3 - 5.6
1975 33,989 15.9 -- -- 3,333 1.6 - 5.1 - 5.9
1976 32,105 15.0 -5.5 - 5.7 3,130 1.5 - 6.1 - 6.3
1977 30,145 13.9 -6.1 - 7.3 2,968 1.4 - 5.2 - 6.7
1978 28,521 13.1 -5.4 - 5.8 2,914 1.3 - 1.8 - 7.1
1979 27,669 12.6 -3.0 - 3.8 2,007 2 0.9 2 -31.1 2 -30.8 2
1980 27,749 12.3 +0.3 - 2.4 1,978 0.9 - 1.4 0.0
1981 27,373 11.9 -1.4 - 3.3 1,937 0.8 - 2.1 -11.1
1982 25,520 11.0 -6.8 -7.6 1,807 0.8 - 6.7 0.0
1983 23,846 10.2 -6.6 - 7.3 1,779 0.8 - 1.5 0.0
1984 22,255 9.4 -6.7 - 7.8 1,729 0.7 - 2.8 -12.5
1985 22,201 9.3 -0.2 - 1.1 1,752 0.7 + 1.3 0.0
1986 22,768 9.4 +2.6 + 1.1 1,782 0.7 + 1.7 0.0
1987 22,517 9.3 -1.1 - 1.1 1,755 0.7 - 1.5 0.0
1988 22,436 9.1 -0.4 - 2.2 1,921 0.8 + 9.5 +14.3
1989 23,495 9.5 +4.7 + 4.4 1,970 0.8 + 2.6 0.0
1990 25,701 10.3 +9.4 + 8.4 1,810 0.7 - 8.1 -12.5
1991 26,283 10.4 +2.3 + 1.0 1,713 0.7 - 5.4 0.0
1992 26,673 10.5 +1.5 + 1.0 1,705 0.7 - 0.5 0.0
1993 25,287 9.8 -5.2 - 6.7 1,631 0.6 - 4.3 -14.3
1994 24,361 9.4 -3.7 -4.1 1,478 0.6 - 9.4 0.0  
1995 22,860 8.7 -6.2 -7.4 1,336 0.5 - 9.6 -16.7
1996 21,337 8.0 -6.7 + 8.0 1,202 0.5 -10.0 0.0
1997 19,851 7.4 -7.0 -7.5  1,166 0.4 -3.0 -20.0
1998 18,361 6.8 -7.5 -8.1 1,112 0.4 -4.6 0.0
1999 17,531 6.4 -4.5 -5.9 856 3 0.3 3 -23.0 3 -25.0 3
2000 16,377 5.8 -6.6 -9.4 … … … …
1. Per 100,000 population.  
2. The large decrease in 1979 occurred because late effects of tuberculosis (e.g., bronchiectasis or fibrosis) and pleurisy with effusion (without 
mention of cause) are no longer included in tuberculosis deaths.
3. Preliminary data obtained from National Center for Health Statistics (NCHS) National Vital Statistics Reports, Vol. 49, No. 3, June 26, 2001.
Ellipses indicate data not available.
Note: Official tuberculosis mortality statistics are compiled by the National Center for Health Statistics, CDC.  Case data after 1974 are not 
comparable to prior years due to changes in the surveillance case definitions which became effective in 1975.
See Surveillance Slide #2.
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Table 2.  Tuberculosis Cases and Case Rates per 100,000 Population by Age Group:
United States, 1990-2000  
 Total 0 -14 15 - 24 25 - 44 45 - 64 65+ Not Stated
Year Cases   No.  % Rate   No.  % Rate   No.  % Rate   No.  % Rate   No.  % Rate No.  %
1990 25,701 1,596 6 3.0 1,867 7 5.1 9,730 38 12.0 6,365 25 13.7 6,115 24 19.6 28 0
1991 26,283 1,662 6 3.0 1,971 7 5.4 10,263 39 12.5 6,297 24 13.5 6,068 23 19.1 22 0
1992 26,673 1,707 6 3.1 1,974 7 5.5 10,444 39 12.7 6,487 24 13.4 6,025 23 18.7 36 0
1993 25,287 1,718 7 3.0 1,841 7 5.1 9,615 38 11.6 6,225 25 12.5 5,847 23 17.8 41 0
1994 24,361 1,695 7 3.0 1,825 7 5.1 9,106 37 11.0 6,141 25 12.1 5,546 23 16.7 48 0
1995 22,860 1,558 7 2.7 1,703 7 4.7 8,241 36 9.9 5,998 26 11.5 5,351 23 16.0 9 0
1996 21,337 1,372 6 2.4 1,656 8 4.6 7,604 36 9.1 5,588 26 10.4 5,103 24 15.1 14 0
1997 19,851 1,265 6 2.2 1,681 8 4.6 6,912 35 8.3 5,297 27 9.6 4,691 24 13.8 5 0
1998 18,361 1,082 6 1.9 1,548 8 4.2 6,365 35 7.6 4,973 27 8.7  4,393 24 12.8 0 0
1999 17,531 1,044 6 1.8 1,516 9 4.0 6,078 35 7.3 4,862 28 8.2 4,028 23 11.7 3 0
2000 16,377 969 6 1.6 1,623 10 4.1 5,588 34 6.6 4,661 28 7.5 3,534 22 10.1  2 0
Note: Denominators for computing 2000 rates were obtained from the U.S. Census Bureau publication, Profiles of General Demographic 
Characteristics, 2000.
See Technical Notes (Appendix A).
See Surveillance Slide #5.
Table 3.  Tuberculosis Cases and Case Rates per 100,000 Population by Race/Ethnicity:
United States, 1990-2000    
White, Black, American Indian/ Asian/ Unknown/
 Total non-Hispanic non-Hispanic  Hispanic1 Alaskan Native Pacific Islander Missing
Year Cases   No.  % Rate   No.  % Rate   No.  % Rate No.  % Rate   No.  % Rate No.  %
1990 25,701 7,836 30 4.2 9,634 37 33.0 4,809 19 21.5 361 1 20.1 3,004 12 43.1 57 0
1991 26,283 7,709 29 4.1 9,536 36 31.9 5,354 20 22.9 342 1 18.5 3,324 13 44.3 18 0
1992 26,673 7,618 29 4.0 9,623 36 31.7 5,437 20 22.4 299 1 16.2 3,649 14 46.3 47 0
1993 25,287 6,922 27 3.6 8,951 35 29.1 5,194 21 20.6 274 1 14.6 3,680 15 44.5 266 1
1994 24,361 6,494 27 3.4 8,345 34 26.8 5,074 21 19.5 332 1 17.4 3,821 16 45.3 295 1
1995 22,860 5,989 26 3.1 7,555 33 23.9 4,847 21 18.0 319 1 16.5 3,997 17 45.9 153 1
1996 21,337 5,506 26 2.8 7,106 33 22.3 4,533 21 16.0 284 1 14.5 3,814 18 41.6 94 0
1997 19,851 4,872 25 2.5 6,610 33 20.5 4,228 21 14.4 264 1 13.4 3,833 19 40.6 44 0
1998 18,361 4,495 24 2.3 5,831 32 17.8 4,099 22 13.6 253 1 12.6 3,623 20 36.6 60 0
1999 17,531 4,224 24 2.2 5,552 32 16.8 3,875 22 12.4 240 1 11.8 3,591 20 35.3 49 0
2000 16,377 3,674 22 1.9 5,161 32 15.2 3,805 23 10.8 236 1 11.4 3,451 21 32.9 50 0
1. Persons of Hispanic origin may be of any race.
Note: Denominators for computing 2000 rates were obtained from the U.S. Census Bureau publication, Profiles of General Demographic 
Characteristics, 2000.
See Technical Notes (Appendix A).
See Surveillance Slide #7.
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Table 4.  Tuberculosis Cases and Case Rates per 100,000 Population by
Origin: United States, 1990-2000
 Total U.S.-born Persons Foreign-born Persons1 Unknown
Year Cases No.  % Rate    No.  % Rate No.  %
1990 25,701 18,997 74 8.3 6,262 24 31.2 442 2
1991 26,283 19,161 73 8.2 6,982 27 33.9 140 1
1992 26,673 19,225 72 8.2 7,270 27 34.2 178 1
1993 25,287 17,464 69 7.4 7,354 29 33.6 469 2
1994 24,361 16,278 67 6.8 7,627 31 33.9 456 2
1995 22,860 14,772 65 6.1 7,930 35 34.2 158 1
1996 21,337 13,333 62 5.5 7,704 36 32.3 300 1
1997 19,851 11,898 60 4.9 7,702 39 31.2 251 1
1998 18,361 10,675 58 4.3 7,591 41 30.0 95 1
1999 17,531 9,809 56 4.0 7,553 43 29.2 169 1
2000 16,377 8,714 53 3.5 7,554 46 25.8 109 1
1. Includes persons born outside the United States, American Samoa, the Federated States of Micronesia, Guam, the 
Republic of the Marshall Islands, Midway Island, the Commonwealth of the Northern Mariana Islands, Puerto Rico,  
the Republic of Palau, U.S. Minor Outlying Islands, U.S. Miscellaneous Pacific Islands, and the U.S. Virgin Islands.
Note:  Denominators for computing rates for years 1990-1999 were obtained from Quarterly Estimates of the United 
States Foreign-born and Native Resident Populations: April 1, 1990, to July 1, 1999 
(www.census.gov/population/estimates/nation/nativity/fbtab001.txt).  Denominators for computing rates 
for 2000 were based on an extrapolation to April 2000 population from estimates in U.S. Census Bureau Current 
Population Reports, P20-534, The Foreign-born Population in the United States: March 2000. 
See Surveillance Slides #9 and #12.
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Table 5.  Tuberculosis Cases by Case Verification Criterion and by Site of Disease:
United States, 1990-2000 
          Verification Criterion1 Site of Disease
Positive Positive Clinical Provider Extra-
Total Culture Smear Case Definition Diagnosis Pulmonary2 pulmonary
Year Cases No. % No. % No. % No. % No. % No. %
1990 25,701 20,897 81 556 2 2,958 12 1,290 5 21,576 84 4,091 16
1991 26,283 21,417 81 388 1 2,992 11 1,486 6 21,937 83 4,327 16
1992 26,673 21,398 80 407 2 3,141 12 1,727 6 22,371 84 4,288 16
1993 25,287 20,081 79 309 1 2,994 12 1,903 8 21,255 84 3,995 16
1994 24,361 19,537 80 236 1 2,794 11 1,794 7 20,385 84 3,964 16
1995 22,860 18,292 80 220 1 2,664 12 1,684 7 18,991 83 3,860 17
1996 21,337 17,234 81 150 1 2,556 12 1,397 7 17,445 82 3,870 18
1997 19,851 16,015 81 177 1 2,355 12 1,304 7 16,285 82 3,554 18
1998 18,361 14,830 81 166 1 2,207 12 1,158 6 14,813 81 3,541 19
1999 17,531 13,997 80 176 1 2,058 12 1,300 7 14,083 80 3,438 20
2000 16,377 13,035 80 169 1 1,901 12  1,272 8 13,142 80 3,220 20
1. Based on the public health surveillance case definition for tuberculosis:  CDC. Case definitions for infectious conditions under public 
health surveillance.  MMWR 1997:46(No. RR-10):40-41.  See Appendix B.
2. Includes cases of both pulmonary and extrapulmonary disease and cases of miliary TB.
Note: See Technical Notes (Appendix A) for a description of national TB surveillance.
Table 6.  Pulmonary Tuberculosis Cases by Sputum Smear and Sputum Culture Results: 
United States, 1990-2000 
Sputum Smear Results Sputum Culture Results  
Total Not Done or Not Done or
Pulmonary Positive Negative Unknown Positive Negative Unknown
Year Cases1 No. % No. % No. % No. % No. % No. %
1990 21,576 9,391 44 6,865 32 5,320 25 14,816 69 2,124 10 4,636 21
1991 21,937 9,095 41 7,281 33 5,561 25 15,022 68 2,232 10 4,683 21
1992 22,371 8,975 40 7,413 33 5,983 27 15,124 68 2,476 11 4,771 21
1993 21,255 9,324 44 7,747 36 4,184 20 14,708 69 2,675 13 3,872 18
1994 20,385 8,845 43 7,770 38 3,770 18 14,080 69 2,618 13 3,687 18
1995 18,991 8,068 42 7,717 41 3,206 17 13,236 70 2,597 14 3,158 17
1996 17,445 7,449 43 7,337 42 2,659 15 12,232 70 2,507 14 2,706 16
1997 16,285 6,882 42 6,878 42 2,525 16 11,481 71 2,226 14 2,578 16
1998 14,813 6,630 45 6,016 41 2,167 15 10,472 71 2,101 14 2,240 15
1999 14,083 6,252 44 5,626 40 2,205 16 9,777 69 2,049 15 2,257 16
2000 13,142 5,865 45 5,332 41 1,945 15 9,214 70 1,912 15 2,016 15
1. Includes cases of both pulmonary and extrapulmonary disease and cases of miliary TB.
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Table 7.  Resistance to Isoniazid with or without Rifampin Resistance in Reported TB
Cases with No Previous TB by Origin: United States, 1993-2000 
Resistant to Isoniazid1 Resistant to Isoniazid and Rifampin1
Total Cases2 U. S.-born Foreign-born3 Total Cases2       U. S.-born   Foreign-born3
Year No. % No. % No. % No. % No. % No. %
1993 1,400 8.4 804 6.8 579 12.4 410 2.5 302 2.6 105 2.3
1994 1,355 8.3 709 6.4 632 12.1 352 2.2 238 2.2 109 2.1
1995 1,171 7.3 554 5.4 615 11.0 252 1.6 168 1.6 84 1.5
1996 1,138 7.4 496 5.2 639 11.3 206 1.3 104 1.1 101 1.8
1997 1,082 7.5 436 5.0 640 11.2 156 1.1 75 0.9 80 1.4
1998 1,012 7.5 366 4.7 644 11.3 130 1.0 55 0.7 74 1.3
1999 904 7.1 284 4.1 618 11.0 128 1.0 39 0.6 89 1.6
2000 851 7.5 261 4.4 587 11.0 120 1.1 38 0.6 82 1.5
1. Isolates may be resistant to other drugs.
2. Includes persons of unknown country of birth.
3. Includes persons born outside the United States, American Samoa, the Federated States of Micronesia, Guam, the Republic of the Marshall 
Islands, Midway Island, the Commonwealth of the Northern Mariana Islands, Puerto Rico, the Republic of Palau, U.S. Minor Outlying Islands, 
U.S. Miscellaneous Pacific Islands, and the U.S. Virgin Islands.
Note:  Data for all years updated through April 17, 2001.
More than 85% of all cases in each group had drug susceptibility test results reported for an initial isolate.
See Surveillance Slides #14 and #15.
Table 8.  Resistance to Isoniazid with or without Rifampin Resistance in Reported TB
Cases with Previous TB by Origin: United States, 1993-2000 
Resistant to Isoniazid1 Resistant to Isoniazid and Rifampin1
Total Cases2 U. S.-born Foreign-born3 Total Cases2       U. S.-born   Foreign-born3
Year No. % No. % No. % No. % No. % No. %
1993 164 16.6 85 12.7 76 25.1 75 7.7 30 4.5 45 15.0
1994 177 17.1 81 11.7 95 28.1 75 7.3 35 5.1 39 11.6
1995 168 17.6 77 13.0 91 25.1 70 7.3 28 4.7 42 11.6
1996 142 16.5 67 12.0 74 24.4 43 5.0 20 3.6 22 7.3
1997 108 14.6 34 7.5 74 25.9 43 5.8 11 2.4 32 11.2
1998 98 13.0 37 7.8 60 22.8 23 3.1 6 1.2 17 6.5
1999 82 12.3 25 6.5 55 19.4 28 4.2 6 1.6 22 7.8
2000 73 12.4 20 5.8  53 21.5 21 3.6 2 0.6 19 7.7
1. Isolates may be resistant to other drugs.
2. Includes persons of unknown country of birth.
3. Includes persons born outside the United States, American Samoa, the Federated States of Micronesia, Guam, the Republic of the Marshall 
Islands, Midway Island, the Commonwealth of the Northern Mariana Islands, Puerto Rico, the Republic of Palau, U.S. Minor Outlying Islands, 
U.S. Miscellaneous Pacific Islands, and the U.S. Virgin Islands.
Note:  Data for all years updated through April 17, 2001.
More than 85% of all cases in each group had drug susceptibility test results reported for an initial isolate.
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Table 9.  Percentage of Reported TB Cases by Initial Drug Regimen, Use of Directly 
Observed Therapy, and Completion of Therapy (COT): United States, 1993-2000  
Directly Observed Therapy3 Therapy
Initial Drug Regimen1,2 Both DOT and <1 Year Indicated4
Year IR      IRZ IRZ,E/S DOT Only Self-Administered COT <1 Year COT
1993 13.0 31.2 40.9 21.7 14.4 63.6 87.5
1994 7.0 23.3 56.3 28.1 20.5 68.5 87.9
1995 5.2 20.3 63.3 37.2 21.5 72.9 89.6
1996 4.2 17.5 67.9 42.5 22.4 75.5 90.2
1997 3.2 15.1 72.4 46.9  23.8 77.7 91.1
1998 2.6 12.9 74.7 51.7 22.4 79.1 90.7
1999 2.2 11.2 77.2 … … … …
2000 1.9 10.3 78.2 … … … …
1. Includes cases in persons alive at diagnosis.
2. I=isoniazid; R=rifampin; Z=pyrazinamide; E=ethambutol; S=streptomycin.  Excluding cases with no information on initial drug 
regimen, 1% were not started on any drugs, less than 1% were started on one drug, and approximately 10% had an initial multidrug 
regimen other than IR, IRZ, and IRZ,E/S.
3. Includes cases in persons alive at diagnosis with initial drug regimen of one or more drugs prescribed.
4. Includes cases in persons alive at diagnosis, with initial drug regimen of one or more drugs prescribed, who did not die during 
therapy.  Excludes persons with initial isolate resistant to rifampin and pediatric (aged <15) cases with meningeal, bone or joint, or 
miliary disease.  See Technical Notes (Appendix A) for description of COT calculation.
Ellipses indicate data not available.
Note:  Data for all years updated through April 17, 2001.
See Surveillance Slides #17 and #18.           
Table 10.  Number and Percentage of Reported TB Cases with HIV Test 
Results and with HIC Coinfection by Age Group: United States, 1993-1999
25-44 Years Old All Ages
HIV HIV HIV HIV
Test Results1 Positive2 Test Results1 Positive2
Year No. % No. % No. % No.  %
1993 4,375 46 2,788 29 7,451 30 3,680 15
1994 4,433 49 2,660 29 7,871 33 3,590 15
1995 4,269 52 2,169 26 8,173 36 3,035 13
1996 4,347 57 1,857 25 8,800 41 2,617 12
1997 4,134 60 1,469 21 8,756 44 2,088 11
1998 3,856 61 1,238 20 8,274 45 1,828 10
1999 3,785 62 1,171 19 8,349 48 1,721 10
1. Rhode Island reported HIV test results in 1998 and 1999.  HIV test results were not reported from California. California 
did provide HIV status for TB cases reported during 1993-1999 in persons also reported with AIDS  (i.e., HIV-positive).  
Includes cases with positive, negative, or indeterminate HIV test results and California cases also reported with AIDS.  
Percentages based on all reported TB cases.
2. Includes cases with HIV-positive test results and California cases also reported with AIDS.  Percentages based on all 
reported TB cases.
Note:  Data for all years updated through April 17, 2000.
See Surveillance Slide #16. 
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Table 11. Tuberculosis Cases by Race/Ethnicity, Sex, and Age: United States, 2000
Race/Ethnicity Age Group Not
    and Sex        All Ages Under 5  5 - 14 15 - 24 25 - 44 45 - 64  65+  Stated
Total Cases 16,377 548 421 1,623 5,588 4,661 3,534 2
White, non-Hispanic 3,674 71 35 131 840 1,186 1,411 0
           Male 2,416 35 24 63 555 888 851 0
           Female 1,258 36 11 68 285 298 560 0
           Unknown 0 0 0 0 0 0 0 0
Black, non-Hispanic 5,161 173 156 480 1,962 1,593 795 2
           Male 3,302 86 81 237 1,251 1,196 450 1
           Female 1,857 86 75 243 711 396 345 1
           Unknown 2 1 0 0 0 1 0 0
Hispanic1 3,805 220 158 635 1,445 852 495 0
           Male 2,415 111 71 388 991 566 288 0
           Female 1,390 109 87 247 454 286 207 0
           Unknown 0 0 0 0 0 0 0 0
American Indian/Alaskan Native 236 18 9 14 64 75 56 0
           Male 139 8 6 9 38 47 31 0
           Female 97 10 3 5 26 28 25 0
           Unknown 0 0 0 0 0 0 0 0
Asian/Pacific Islander 3,451 65 60 357 1,261 940 768 0
           Male 1,923 34 26 166 656 546 495 0
           Female 1,526 31 34 191 603 394 273 0
           Unknown 2 0 0 0 2 0 0 0
Not Stated 50 1 3 6 16 15 9 0
           Male 30 1 1 3 8 10 7 0
           Female 20 0 2 3 8 5 2 0
           Unknown 0 0 0 0 0 0 0 0
1. Persons of Hispanic origin may be of any race.
See Surveillance Slide #7.
Table 12. Tuberculosis Case Rates per 100,000 Population by Race/Ethnicity, 
Sex, and Age: United States, 2000 
Race/Ethnicity Age Group   
   and Sex     All Ages Under 5    5 - 14    15 - 24    25 - 44    45 - 64     65+  
Total Cases 5.8 2.8 1.0 4.1 6.6 7.5 9.9
White, non-Hispanic 1.8 0.6 0.1 0.5 1.4 2.4 4.7
           Male 6.4 3.2 1.1 4.0 7.3 8.2 6.9
           Female 1.2 0.6 0.1 0.5 1.0 1.2 3.2
Black, non-Hispanic 2.9 0.7 0.2 0.5 2.4 4.3 27.5
           Male 1.4 0.6 0.2 0.4 1.1 1.2 39.6
           Female 10.3 6.6 2.5 8.6 12.7 11.1 19.7
Hispanic1 22.3 7.0 2.3 8.1 28.5 46.1 24.9
           Male 11.8 8.0 2.8 7.8 14.8 13.7 34.4
           Female 8.4 6.1 2.8 8.9 8.9 11.0 18.1
American Indian/Alaskan Native 15.8 8.0 3.4 12.8 19.6 26.4 36.0
           Male 8.9 6.4 2.7 7.8 9.4 12.1 47.2
           Female 9.1 11.8 1.5 2.7 8.3 14.2 27.8
Asian/Pacific Islander 14.8 8.4 1.0 1.1 16.7 28.2 93.0
           Male 9.0 6.2 1.6 4.5 6.9 18.7 142.4
           Female 27.2 7.2 4.2 24.6 31.1 33.6 57.1
1. Persons of Hispanic origin may be of any race.
Note: Denominators for computing rates were extrapolated to the April 2000 population based in U.S. Census
Bureau July 1, 2000, population estimates.
See Surveillance Slide #8.
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Table 13. Tuberculosis Cases in U.S.-born Persons by Race/Ethnicity, Sex, and Age:
United States, 2000                     
Race/Ethnicity Age Group   Not
   and Sex              All Ages Under 5 5 - 14 15 - 24 25 - 44 45 - 64      65+   Stated
Total Cases 8,714 451 253 470 2,504 2,809 2,226 1
White, non-Hispanic 3,121 63 23 71 670 1,054 1,240 0
           Male 2,096 32 16 32 445 807 764 0
           Female 1,025 31 7 39 225 247 476 0
           Unknown 0 0 0 0 0 0 0 0
Black, non-Hispanic 4,112 160 107 250 1,462 1,396 736 1
           Male 2,692 82 51 121 955 1,065 417 1
           Female 1,419 78 56 129 507 330 319 0
           Unknown 1 0 0 0 0 1 0 0
Hispanic1 1,037 166 92 109 263 249 158 0
           Male 618 81 46 50 182 171 88 0
           Female 419 85 46 59 81 78 70 0
           Unknown 0 0 0 0 0 0 0 0
American Indian/Alaskan Native 225 18 9 13 60 72 53 0
           Male 132 8 6 8 36 45 29 0
           Female 93 10 3 5 24 27 24 0
           Unknown 0 0 0 0 0 0 0 0
Asian/Pacific Islander 196 43 21 26 44 28 34 0
           Male 110 24 8 13 24 19 22 0
           Female 86 19 13 13 20 9 12 0
           Unknown 0 0 0 0 0 0 0 0
Not Stated 23 1 1 1 5 10 5 0
           Male 18 1 0 1 4 7 5 0
           Female 5 0 1 0 1 3 0 0
           Unknown 0 0 0 0 0 0 0 0
1. Persons of Hispanic origin may be of any race.
 
Table 14. Tuberculosis Cases in Foreign-born Persons1 by Race/Ethnicity, Sex, and
Age: United States, 2000
                        
Race/Ethnicity Age Group   Not
   and Sex               All Ages Under 5 5 - 14 15 - 24 25 - 44 45 - 64      65+   Stated
Total Cases 7,554 93 161 1,143 3,047 1,822 1,287 1 
White, non-Hispanic 539 8 12 59 168 130 162 0
           Male 310 3 8 31 108 79 81 0
           Female 229 5 4 28 60 51 81 0
           Unknown 0 0 0 0 0 0 0 0
Black, non-Hispanic 1,026 13 47 229 493 187 56 1
           Male 595 4 28 116 293 124 30 0
           Female 430 8 19 113 200 63 26 1
           Unknown 1 1 0 0 0 0 0 0
Hispanic2 2,727 52 63 521 1,164 591 336 0
           Male 1,765 30 23 333 795 385 199 0
           Female 962 22 40 188 369 206 137 0
           Unknown 0 0 0 0 0 0 0 0
American Indian/Alaskan Native 10 0 0 0 4 3 3 0
           Male 6 0 0 0 2 2 2 0
           Female 4 0 0 0 2 1 1 0
           Unknown 0 0 0 0 0 0 0 0
Asian/Pacific Islander 3,235 20 38 330 1,212 908 727 0
           Male 1,798 9 17 152 630 523 467 0
           Female 1,435 11 21 178 580 385 260 0
           Unknown 2 0 0 0 2 0 0 0
Not Stated 17 0 1 4 6 3 3 0
           Male 8 0 0 2 3 2 1 0
           Female 9 0 1 2 3 1 2 0
           Unknown 0 0 0 0 0 0 0 0
1. Includes persons born outside the United States, American Samoa, the Federated States of Micronesia, Guam, the Republic
of the Marshall Islands, Midway Island, the Commonwealth of the Northern Mariana Islands, Puerto Rico, the Republic of Palau, 
U.S. Minor Outlying Islands, U.S. Miscellaneous Pacific Islands, and the U.S. Virgin Islands.
2. Persons of Hispanic origin may be of any race.    
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Table 15.  Tuberculosis Cases and Case Rates per 100,000 Population: States, 2000 and 1999
 Rank According April 1, 2000
    Cases    Case Rates to Rate                Census
State 2000 1999 2000 1999 2000 1999              Population
United States 16,377 17,531 5.8 6.4 -- -- 281,421,906
Alabama 310 314 7.0 7.2 11 11 4,447,100
Alaska 108 61 17.2 9.8 1 4 626,932
Arizona 261 262 5.1 5.5 18 19 5,130,632
Arkansas 199 181 7.4 7.1 6 12 2,673,400
California 3,297 3,606 9.7 10.9 3 2 33,871,648
Colorado 97 88 2.3 2.2 38 39 4,301,261
Connecticut 105 121 3.1 3.7 31 31 3,405,565
Delaware 28 34 3.6 4.5 28 24 783,600
District of Columbia1 85 70 14.9 13.5 -- -- 572,059
Florida 1,171 1,277 7.3 8.5 8 6 15,982,378
Georgia 703 665 8.6 8.5 5 5 8,186,453
Hawaii 136 184 11.2 15.5 2 1 1,211,537
Idaho 16 16 1.2 1.3 47 46 1,293,953
Illinois 743 825 6.0 6.8 15 15 12,419,293
Indiana 145 150 2.4 2.5 36 37 6,080,485 
Iowa 40 58 1.4 2.0 46 41 2,926,324
Kansas 77 69 2.9 2.6 34 36 2,688,418
Kentucky 147 209 3.6 5.3 26 21 4,041,769
Louisiana 331 357 7.4 8.2 7 8 4,468,976
Maine 24 23 1.9 1.8 41 43 1,274,923
Maryland 282 294 5.3 5.7 17 18 5,296,486
Massachusetts 285 270 4.5 4.4 21 26 6,349,097
Michigan 287 351 2.9 3.6 33 33 9,938,444
Minnesota 178 201 3.6 4.2 27 27 4,919,479
Mississippi 173 215 6.1 7.8 14 10 2,844,658 
Missouri 211 208 3.8 3.8 25 28 5,595,211
Montana 21 14 2.3 1.6 37 44 902,195
Nebraska 24 18 1.4 1.1 45 48 1,711,263
Nevada 96 93 4.8 5.1 19 22 1,998,257
New Hampshire 22 19 1.8 1.6 43 45 1,235,786
New Jersey 565 571 6.7 7.0 13 13 8,414,350
New Mexico 46 64 2.5 3.7 35 32 1,819,046
New York 1,744 1,837 9.2 10.1 4 3 18,976,457
North Carolina 447 488 5.6 6.4 16 16 8,049,313
North Dakota 5 7 0.8 1.1 49 47 642,200
Ohio 340 317 3.0 2.8 32 35 11,353,140
Oklahoma 154 208 4.5 6.2 22 17 3,450,654
Oregon 119 123 3.5 3.7 29 30 3,421,399
Pennsylvania 383 454 3.1 3.8 30 29 12,281,054
Rhode Island 49 53 4.7 5.3 20 20 1,048,319
South Carolina 286 315 7.1 8.1 10 9 4,012,012
South Dakota 16 21 2.1 2.9 40 34 754,844
Tennessee 383 382 6.7 7.0 12 14 5,689,283
Texas 1,506 1,649 7.2 8.2 9 7 20,851,820
Utah 49 40 2.2 1.9 39 42 2,233,169
Vermont 4 3 0.7 0.5 50 50 608,827
Virginia 292 334 4.1 4.9 24 23 7,078,515
Washington 258 258 4.4 4.5 23 25 5,894,121
West Virginia 33 41 1.8 2.3 42 38 1,808,344
Wisconsin 92 110 1.7 2.1 44 40 5,363,675
Wyoming 4 3 0.8 0.6 48 49 493,782
American Samoa1,2 ... 4 ... 6.3 -- -- 57,291
Fed. States of Micronesia1,2 ... ... ... ... -- -- ...
Guam1,2 54 69 34.9 45.4 -- -- 154,805
N. Mariana Islands1,2 75 66 108.3 95.4 -- -- 69,221
Puerto Rico1,2 174 200 4.6 5.1 -- -- 3,808,610
Republic of Palau1,2 ... 11 ... 59.7 -- -- ...
U.S. Virgin Islands1,2 ... ... ... ... -- -- 108,612
1. Not ranked with the states.
2. Not included in U.S. totals.
Ellipses indicate data not available.
Note: Denominators for computing 2000 rates for the states, the District of Columbia, and Puerto Rico were obtained from the U.S.
Census Bureau(www.census.gov/population/www/cen2000/respop.html).  Official Census 2000 population for American Samoa,
Guam, the Commonwealth of the Northern Mariana Islands, and the U.S. Virgin Islands were obtained from U.S. Census Bureau press
release CB01-CN.1, July 3, 2001.  Census 2000 population not yet available for other jurisdictions.
See Surveillance Slide #4.
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Table 16. Tuberculosis Cases by Age Group: States, 2000
                                Total Unknown or
State Cases Under 5    5 - 14  15 - 24 25 - 44 45 - 64      65+ Missing
United States 16,377 548 421 1,623 5,588 4,661 3,534 2
Alabama 310 8 8 16 91 89 98 0
Alaska 108 18 11 13 34 20 12 0
Arizona 261 12 6 33 91 65 54 0
Arkansas 199 9 16 20 41 44 69 0
California 3,297 116 89 328 1,059 943 762 0
Colorado 97 5 0 13 31 24 24 0
Connecticut 105 3 3 10 43 21 25 0
Delaware 28 2 1 7 8 6 4 0
District of Columbia 85 3 1 6 31 31 13 0
Florida 1,171 33 21 92 444 386 195 0
Georgia 703 45 18 85 225 229 100 1
Hawaii 136 2 0 9 35 49 41 0
Idaho 16 1 0 3 4 3 5 0
Illinois 743 18 18 74 255 208 170 0
Indiana 145 10 4 9 40 39 43 0
Iowa 40 2 1 4 20 7 6 0
Kansas 77 3 2 9 28 20 15 0
Kentucky 147 3 0 8 32 44 60 0
Louisiana 331 14 12 22 102 110 71 0
Maine 24 0 1 3 4 11 5 0
Maryland 282 4 4 40 98 69 67 0
Massachusetts 285 5 6 32 110 71 61 0
Michigan 287 14 4 32 92 87 58 0
Minnesota 178 5 5 50 65 36 17 0
Mississippi 173 3 6 3 55 56 50 0
Missouri 211 4 7 12 66 61 61 0
Montana 21 0 0 0 9 9 3 0
Nebraska 24 2 1 3 10 4 4 0
Nevada 96 1 7 6 37 30 15 0
New Hampshire 22 0 2 4 10 6 0 0
New Jersey 565 12 12 68 211 148 114 0
New Mexico 46 0 1 2 5 16 22 0
New York 1,744 39 56 175 698 462 314 0
North Carolina 447 15 3 46 160 110 113 0
North Dakota 5 0 1 0 0 1 3 0
Ohio 340 10 5 44 99 90 92 0
Oklahoma 154 9 2 10 53 41 39 0
Oregon 119 8 3 12 52 25 19 0
Pennsylvania 383 14 11 35 123 95 104 1
Rhode Island 49 3 2 4 17 12 11 0
South Carolina 286 5 5 23 98 85 70 0
South Dakota 16 1 0 1 2 6 6 0
Tennessee 383 11 5 32 115 106 114 0
Texas 1,506 64 46 148 529 464 255 0
Utah 49 1 0 7 15 18 8 0
Vermont 4 0 0 0 1 2 1 0
Virginia 292 6 8 31 107 94 46 0
Washington 258 4 5 26 96 73 54 0
West Virginia 33 0 0 3 4 13 13 0
Wisconsin 92 1 2 10 32 19 28 0
Wyoming 4 0 0 0 1 3 0 0
American Samoa1 ... ... ... ... ... ... ... ...
Fed. States of Micronesia1 ... ... ... ... ... ... ... ...
Guam1 54 0 2 4 15 22 11 0
N. Mariana Islands1 75 1 0 14 41 16 3 0
Puerto Rico1 174 4 1 10 63 52 44 0
Republic of Palau1 ... ... ... ... ... ... ... ...
U.S. Virgin Islands1 ... ... ... ... ... ... ... ...
1. Not included in U.S. totals.
Ellipses indicate data not available.
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Table 17. Tuberculosis Cases by Race/Ethnicity: States, 2000
American Indian Asian Unknown
      Total White, Black,      or or or
State Cases non-Hispanic non-Hispanic Hispanic1   Alaskan Native Pacific Islander Missing
United States 16,377 3,674 5,161 3,805 236 3,451 50
Alabama 310 113 176 13 1 7 0
Alaska 108 10 9 1 71 17 0
Arizona 261 41 20 141 29 27 3
Arkansas 199 87 71 19 1 20 1
California 3,297 388 323 1,200 15 1,368 3
Colorado 97 25 12 38 5 17 0
Connecticut 105 39 31 18 0 16 1
Delaware 28 3 9 7 0 9 0
District of Columbia 85 7 61 12 1 4 0
Florida 1,171 295 594 218 2 62 0
Georgia 703 126 428 79 0 62 8
Hawaii 136 1 0 0 0 134 1
Idaho 16 8 0 5 0 3 0
Illinois 743 150 300 146 7 136 4
Indiana 145 72 40 22 0 11 0
Iowa 40 17 5 9 0 9 0
Kansas 77 22 16 15 0 23 1
Kentucky 147 111 21 8 1 5 1
Louisiana 331 109 177 11 0 31 3
Maine 24 17 3 2 0 2 0
Maryland 282 56 130 34 0 62 0
Massachusetts 285 89 71 41 1 83 0
Michigan 287 87 146 18 1 35 0
Minnesota 178 19 91 30 3 34 1
Mississippi 173 61 96 4 1 11 0
Missouri 211 96 77 11 0 25 2
Montana 21 4 0 0 16 1 0
Nebraska 24 3 9 5 2 5 0
Nevada 96 27 14 26 3 26 0
New Hampshire 22 6 6 1 0 9 0
New Jersey 565 103 166 126 1 169 0
New Mexico 46 4 1 26 12 2 1
New York 1,744 252 598 460 2 428 4
North Carolina 447 120 235 67 1 24 0
North Dakota 5 3 1 0 1 0 0
Ohio 340 133 160 20 0 26 1
Oklahoma 154 76 25 11 26 16 0
Oregon 119 45 15 30 3 26 0
Pennsylvania 383 120 138 33 1 84 7
Rhode Island 49 16 11 10 1 11 0
South Carolina 286 56 199 15 0 16 0
South Dakota 16 4 3 0 9 0 0
Tennessee 383 187 146 33 1 11 5
Texas 1,506 269 351 730 3 150 3
Utah 49 22 5 15 0 7 0
Vermont 4 4 0 0 0 0 0
Virginia 292 58 96 46 0 92 0
Washington 258 64 43 33 10 108 0
West Virginia 33 24 6 1 0 2 0
Wisconsin 92 23 26 14 4 25 0
Wyoming 4 2 0 1 1 0 0
American Samoa2 ... ... ... ... ... ... ...
Fed. States of Micronesia2 ... ... ... ... ... ... ...
Guam2 54 0 0 0 0 54 0
N. Mariana Islands2 75 0 0 1 0 74 0
Puerto Rico2 174 0 0 173 0 1 0
Republic of Palau2 ... ... ... ... ... ... ...
U.S. Virgin Islands2 ... ... ... ... ... ... ...
1. Persons of Hispanic origin may be of any race.
2. Not included in U.S. totals.
Ellipses indicate data not available.
   23 
Table 18. Tuberculosis Cases, U.S.-born Persons and Foreign-born Persons: 
States, 2000
        Total  U.S.-born Persons Foreign-born Persons1    Unknown
State Cases No. % No. % No. %
United States 16,377 8,714 53.2 7,554 46.1 109 0.7
Alabama 310 288 92.9 22 7.1 0 0.0
Alaska 108 92 85.2 16 14.8 0 0.0
Arizona 261 113 43.3 146 55.9 2 0.8
Arkansas 199 169 84.9 23 11.6 7 3.5
California 3,297 911 27.6 2,371 71.9 15 0.5
Colorado 97 38 39.2 59 60.8 0 0.0
Connecticut 105 44 41.9 61 58.1 0 0.0
Delaware 28 9 32.1 19 67.9 0 0.0
District of Columbia 85 61 71.8 24 28.2 0 0.0
Florida 1,171 720 61.5 449 38.3 2 0.2
Georgia 703 545 77.5 154 21.9 4 0.6
Hawaii 136 30 22.1 104 76.5 2 1.5
Idaho 16 11 68.8 5 31.3 0 0.0
Illinois 743 492 66.2 250 33.6 1 0.1
Indiana 145 109 75.2 34 23.4 2 1.4
Iowa 40 14 35.0 26 65.0 0 0.0
Kansas 77 37 48.1 38 49.4 2 2.6
Kentucky 147 132 89.8 13 8.8 2 1.4
Louisiana 331 296 89.4 33 10.0 2 0.6
Maine 24 16 66.7 8 33.3 0 0.0
Maryland 282 141 50.0 141 50.0 0 0.0
Massachusetts 285 81 28.4 204 71.6 0 0.0
Michigan 287 196 68.3 91 31.7 0 0.0
Minnesota 178 32 18.0 146 82.0 0 0.0
Mississippi 173 161 93.1 12 6.9 0 0.0
Missouri 211 161 76.3 50 23.7 0 0.0
Montana 21 21 100.0 0 0.0 0 0.0
Nebraska 24 9 37.5 15 62.5 0 0.0
Nevada 96 41 42.7 54 56.3 1 1.0
New Hampshire 22 5 22.7 17 77.3 0 0.0
New Jersey 565 214 37.9 349 61.8 2 0.4
New Mexico 46 28 60.9 16 34.8 2 4.3
New York 1,744 704 40.4 1,000 57.3 40 2.3
North Carolina 447 335 74.9 112 25.1 0 0.0
North Dakota 5 4 80.0 1 20.0 0 0.0
Ohio 340 239 70.3 100 29.4 1 0.3
Oklahoma 154 128 83.1 25 16.2 1 0.6
Oregon 119 52 43.7 67 56.3 0 0.0
Pennsylvania 383 236 61.6 131 34.2 16 4.2
Rhode Island 49 22 44.9 27 55.1 0 0.0
South Carolina 286 255 89.2 31 10.8 0 0.0
South Dakota 16 13 81.3 3 18.8 0 0.0
Tennessee 383 323 84.3 60 15.7 0 0.0
Texas 1,506 893 59.3 612 40.6 1 0.1
Utah 49 24 49.0 25 51.0 0 0.0
Vermont 4 3 75.0 1 25.0 0 0.0
Virginia 292 105 36.0 183 62.7 4 1.4
Washington 258 82 31.8 176 68.2 0 0.0
West Virginia 33 32 97.0 1 3.0 0 0.0
Wisconsin 92 44 47.8 48 52.2 0 0.0
Wyoming 4 3 75.0 1 25.0 0 0.0
1. Includes persons born outside the United States, American Samoa, the Federated States of Micronesia, Guam, the Republic of the 
Marshall Islands, Midway Island, the Commonwealth of the Northern Mariana Islands, Puerto Rico, the Republic of Palau, U.S. Minor 
Outlying Islands, U.S. Miscellaneous Pacific Islands, and the U.S. Virgin Islands.
See Surveillance Slide #10.
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Table 19. Tuberculosis Cases in Foreign-born Persons1 by Country of Origin: States, 2000
Country of Origin
  Unknown
Total Rep. Of Rep. of All or
State Cases Mexico Philippines Vietnam   India    China Haiti Korea Others2 Missing
United States 7,554 1,773 859 669 562 412 297 208 2,770 4
Alabama 22 7 1 2 2 0 0 0 10 0
Alaska 16 0 13 0 0 0 0 0 3 0
Arizona 146 97 6 8 4 3 0 0 28 0
Arkansas 23 8 2 1 1 0 0 1 9 1
California 2,371 756 461 307 111 156 1 77 502 0
Colorado 59 26 1 5 3 3 0 2 19 0
Connecticut 61 3 4 1 9 1 3 1 39 0
Delaware 19 3 1 0 0 0 1 2 12 0
District of Columbia 24 0 2 0 0 0 0 0 22 0
Florida 449 44 21 10 15 8 151 2 198 0
Georgia 154 39 3 24 16 3 1 3 65 0
Hawaii 104 0 84 1 0 6 0 2 11 0
Idaho 5 1 0 1 1 0 0 0 2 0
Illinois 250 71 30 10 52 9 0 12 66 0
Indiana 34 13 2 2 5 0 0 0 12 0
Iowa 26 7 1 6 2 0 0 0 10 0
Kansas 38 10 3 10 1 1 0 2 11 0
Kentucky 13 5 0 0 2 2 0 0 4 0
Louisiana 33 2 2 15 2 2 0 0 10 0
Maine 8 1 1 0 2 0 0 0 4 0
Maryland 141 8 14 10 10 5 4 7 82 1
Massachusetts 204 2 5 21 15 19 28 4 110 0
Michigan 91 11 4 1 20 5 0 4 46 0
Minnesota 146 10 0 9 6 0 1 0 120 0
Mississippi 12 2 1 3 2 1 0 0 3 0
Missouri 50 4 2 10 4 2 2 2 24 0
Montana 0 0 0 0 0 0 0 0 0 0
Nebraska 15 4 1 3 0 0 0 0 7 0
Nevada 54 19 17 2 1 3 0 2 10 0
New Hampshire 17 0 1 0 5 1 1 0 9 0
New Jersey 349 8 39 17 72 10 19 15 169 0
New Mexico 16 14 0 0 2 0 0 0 0 0
New York 1,000 51 49 20 77 124 79 33 566 1
North Carolina 112 45 1 5 8 2 1 0 50 0
North Dakota 1 0 0 0 0 0 0 0 1 0
Ohio 100 9 1 3 16 2 0 4 65 0
Oklahoma 25 7 0 7 3 1 0 0 7 0
Oregon 67 21 1 9 6 6 0 2 22 0
Pennsylvania 131 9 9 23 16 11 2 5 55 1
Rhode Island 27 1 2 0 0 2 2 0 20 0
South Carolina 31 12 4 1 4 2 0 2 6 0
South Dakota 3 0 0 0 0 0 0 0 3 0
Tennessee 60 22 3 3 5 1 0 0 26 0
Texas 612 371 16 60 32 7 1 7 118 0
Utah 25 8 1 4 0 0 0 0 12 0
Vermont 1 0 0 0 0 0 0 0 1 0
Virginia 183 5 22 20 17 5 0 6 108 0
Washington 176 25 27 32 8 7 0 11 66 0
West Virginia 1 0 0 0 1 0 0 0 0 0
Wisconsin 48 11 1 3 4 2 0 0 27 0
Wyoming 1 1 0 0 0 0 0 0 0 0
1. Includes persons born outside the United States, American Samoa, the Federated States of Micronesia, Guam, the Republic of the Marshall 
Islands, Midway Island, the Commonwealth of the Northern Mariana Islands, Puerto Rico, the Republic of Palau, U.S. Minor Outlying Islands, 
U.S. Miscellaneous Pacific Islands, and the U.S. Virgin Islands.
2. Includes 144 countries.
See Surveillance Slide #11.
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Table 20. Tuberculosis Cases in Foreign-born Persons1 by Number of Years in the United States: States, 
2000 
    Unknown or
       Total   <1 Year    1 - 4     5 - 9   10 - 19   20+   Missing
State Cases No. % No. % No. % No. % No. % No. %
United States 7,554 1,592 21.1 1,541 20.4 1,023 13.5 1,230 16.3 1,014 13.4 1,154 15.3
Alabama 22 9 40.9 10 45.5 0 0.0 2 9.1 1 4.5 0 0.0
Alaska 16 3 18.8 1 6.3 0 0.0 1 6.3 0 0.0 11 68.8
Arizona 146 37 25.3 25 17.1 17 11.6 18 12.3 20 13.7 29 19.9
Arkansas 23 4 17.4 3 13.0 1 4.3 4 17.4 1 4.3 10 43.5
California 2,371 405 17.1 348 14.7 323 13.6 504 21.3 454 19.1 337 14.2
Colorado 59 23 39.0 13 22.0 6 10.2 3 5.1 5 8.5 9 15.3
Connecticut 61 18 29.5 17 27.9 7 11.5 6 9.8 5 8.2 8 13.1
Delaware 19 10 52.6 6 31.6 2 10.5 0 0.0 1 5.3 0 0.0
District of Columbia 24 7 29.2 7 29.2 2 8.3 4 16.7 1 4.2 3 12.5
Florida 449 91 20.3 84 18.7 71 15.8 70 15.6 69 15.4 64 14.3
Georgia 154 33 21.4 45 29.2 20 13.0 18 11.7 7 4.5 31 20.1
Hawaii 104 37 35.6 9 8.7 16 15.4 18 17.3 14 13.5 10 9.6
Idaho 5 0 0.0 1 20.0 1 20.0 0 0.0 2 40.0 1 20.0
Illinois 250 35 14.0 63 25.2 34 13.6 35 14.0 48 19.2 35 14.0
Indiana 34 12 35.3 7 20.6 3 8.8 3 8.8 4 11.8 5 14.7
Iowa 26 10 38.5 7 26.9 3 11.5 3 11.5 0 0.0 3 11.5
Kansas 38 17 44.7 9 23.7 5 13.2 5 13.2 2 5.3 0 0.0
Kentucky 13 6 46.2 2 15.4 1 7.7 1 7.7 0 0.0 3 23.1
Louisiana 33 9 27.3 5 15.2 3 9.1 2 6.1 5 15.2 9 27.3
Maine 8 2 25.0 1 12.5 2 25.0 1 12.5 0 0.0 2 25.0
Maryland 141 39 27.7 26 18.4 14 9.9 18 12.8 5 3.5 39 27.7
Massachusetts 204 53 26.0 58 28.4 25 12.3 41 20.1 22 10.8 5 2.5
Michigan 91 32 35.2 30 33.0 11 12.1 10 11.0 8 8.8 0 0.0
Minnesota 146 41 28.1 53 36.3 18 12.3 15 10.3 5 3.4 14 9.6
Mississippi 12 5 41.7 3 25.0 0 0.0 2 16.7 1 8.3 1 8.3
Missouri 50 13 26.0 16 32.0 9 18.0 6 12.0 4 8.0 2 4.0
Montana 0 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0
Nebraska 15 2 13.3 5 33.3 5 33.3 1 6.7 1 6.7 1 6.7
Nevada 54 13 24.1 5 9.3 8 14.8 16 29.6 6 11.1 6 11.1
New Hampshire 17 7 41.2 3 17.6 2 11.8 0 0.0 1 5.9 4 23.5
New Jersey 349 67 19.2 77 22.1 40 11.5 42 12.0 21 6.0 102 29.2
New Mexico 16 3 18.8 1 6.3 5 31.3 4 25.0 1 6.3 2 12.5
New York 1,000 182 18.2 216 21.6 141 14.1 157 15.7 97 9.7 207 20.7
North Carolina 112 39 34.8 38 33.9 15 13.4 11 9.8 1 0.9 8 7.1
North Dakota 1 0 0.0 1 100.0 0 0.0 0 0.0 0 0.0 0 0.0
Ohio 100 31 31.0 22 22.0 5 5.0 8 8.0 12 12.0 22 22.0
Oklahoma 25 3 12.0 4 16.0 3 12.0 1 4.0 1 4.0 13 52.0
Oregon 67 17 25.4 12 17.9 12 17.9 8 11.9 5 7.5 13 19.4
Pennsylvania 131 23 17.6 30 22.9 18 13.7 14 10.7 7 5.3 39 29.8
Rhode Island 27 4 14.8 3 11.1 2 7.4 2 7.4 1 3.7 15 55.6
South Carolina 31 11 35.5 11 35.5 5 16.1 2 6.5 2 6.5 0 0.0
South Dakota 3 1 33.3 2 66.7 0 0.0 0 0.0 0 0.0 0 0.0
Tennessee 60 14 23.3 25 41.7 8 13.3 5 8.3 3 5.0 5 8.3
Texas 612 117 19.1 150 24.5 101 16.5 104 17.0 138 22.5 2 0.3
Utah 25 4 16.0 6 24.0 5 20.0 6 24.0 1 4.0 3 12.0
Vermont 1 0 0.0 1 100.0 0 0.0 0 0.0 0 0.0 0 0.0
Virginia 183 48 26.2 41 22.4 22 12.0 20 10.9 16 8.7 36 19.7
Washington 176 40 22.7 28 15.9 25 14.2 30 17.0 10 5.7 43 24.4
West Virginia 1 1 100.0 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0
Wisconsin 48 13 27.1 11 22.9 7 14.6 9 18.8 6 12.5 2 4.2
Wyoming 1 1 100.0 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0
1. Includes persons born outside the United States, American Samoa, the Federated States of Micronesia, Guam, the Republic of the
Marshall Islands, Midway Island, the Commonwealth of the Northern Mariana Islands, Puerto Rico, the Republic of Palau, U.S. Minor
Outlying Islands, U.S. Miscellaneous  Pacific Islands, and the U.S. Virgin Islands.
See Surveillance Slide #13.  
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Table 21.  Tuberculosis Cases by Form of Disease: States, 2000
           Cases with Both Pulmonary
     and Extrapulmonary Disease
   Total Pulmonary1 Extrapulmonary2 Total3 Miliary
State Cases No. % No. %  No. %          No.
United States 16,377 11,894 72.6 3,220 19.7 1,248 7.6 298
Alabama 310 251 81.0 44 14.2 15 4.8 1
Alaska 108 95 88.0 11 10.2 2 1.9 2
Arizona 261 208 79.7 26 10.0 27 10.3 4
Arkansas 199 167 83.9 6 3.0 26 13.1 2
California 3,297 2,414 73.2 620 18.8 261 7.9 59
Colorado 97 58 59.8 27 27.8 12 12.4 1
Connecticut 105 68 64.8 30 28.6 7 6.7 2
Delaware 28 21 75.0 6 21.4 1 3.6 1
District of Columbia 85 71 83.5 12 14.1 2 2.4 0
Florida 1,171 922 78.7 178 15.2 67 5.7 15
Georgia 703 540 76.8 117 16.6 46 6.5 11
Hawaii 136 114 83.8 18 13.2 4 2.9 0
Idaho 16 13 81.3 2 12.5 1 6.3 0
Illinois 743 530 71.3 166 22.3 47 6.3 13
Indiana 145 125 86.2 11 7.6 9 6.2 4
Iowa 40 34 85.0 4 10.0 2 5.0 0
Kansas 77 47 61.0 22 28.6 6 7.8 0
Kentucky 147 122 83.0 18 12.2 5 3.4 1
Louisiana 331 277 83.7 42 12.7 11 3.3 2
Maine 24 16 66.7 6 25.0 2 8.3 0
Maryland 282 188 66.7 56 19.9 38 13.5 16
Massachusetts 285 177 62.1 91 31.9 17 6.0 6
Michigan 287 191 66.6 80 27.9 16 5.6 2
Minnesota 178 88 49.4 76 42.7 14 7.9 5
Mississippi 173 144 83.2 25 14.5 4 2.3 0
Missouri 211 158 74.9 36 17.1 17 8.1 3
Montana 21 13 61.9 7 33.3 1 4.8 0
Nebraska 24 10 41.7 11 45.8 3 12.5 1
Nevada 96 79 82.3 10 10.4 7 7.3 3
New Hampshire 22 12 54.5 8 36.4 2 9.1 0
New Jersey 565 375 66.4 135 23.9 55 9.7 17
New Mexico 46 29 63.0 11 23.9 6 13.0 0
New York 1,744 1,191 68.3 378 21.7 174 10.0 39
North Carolina 447 332 74.3 84 18.8 31 6.9 6
North Dakota 5 2 40.0 3 60.0 0 0.0 0
Ohio 340 232 68.2 95 27.9 13 3.8 5
Oklahoma 154 108 70.1 25 16.2 21 13.6 9
Oregon 119 82 68.9 29 24.4 8 6.7 3
Pennsylvania 383 256 66.8 103 26.9 24 6.3 6
Rhode Island 49 27 55.1 13 26.5 9 18.4 1
South Carolina 286 177 61.9 74 25.9 32 11.2 16
South Dakota 16 10 62.5 3 18.8 3 18.8 0
Tennessee 383 299 78.1 54 14.1 30 7.8 8
Texas 1,506 1,120 74.4 271 18.0 115 7.6 22
Utah 49 31 63.3 12 24.5 6 12.2 2
Vermont 4 4 100.0 0 0.0 0 0.0 0
Virginia 292 205 70.2 61 20.9 26 8.9 6
Washington 258 176 68.2 66 25.6 16 6.2 2
West Virginia 33 25 75.8 6 18.2 2 6.1 1
Wisconsin 92 58 63.0 29 31.5 5 5.4 1
Wyoming 4 2 50.0 2 50.0 0 0.0 0
American Samoa4 ... ... ... ... ... ... ... ...
Fed. States of Micronesia4 ... ... ... ... ... ... ... ...
Guam4 54 47 87.0 6 11.1 0 0.0 0
N. Mariana Islands4 75 55 73.3 11 14.7 9 12.0 2
Puerto Rico4 174 149 85.6 24 13.8 1 0.6 0
Republic of Palau4 ... ... ... ... ... ... ... ...
U.S. Virgin Islands4 ... ... ... ... ... ... ... ...
1. Includes cases with pulmonary listed as major site of disease and no additional site of disease.
2. Includes cases with pleural, lymphatic, bone and/or joint, meningeal, peritoneal, or other site, excluding pulmonary, listed as major site of 
disease.
3. Includes miliary cases.
4. Not included in U.S. totals. 
Ellipses indicate data not available.
Note:15 (0.1%) cases had missing and/or unknown site of disease.
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Table 22.  Extrapulmonary Tuberculosis Cases by Site of Disease: States, 2000
  Total
 Extra-
 pulmonary Bone and/ Genito-
State Cases Pleural Lymphatic or Joint urinary Meningeal Peritoneal      Other
United States 3,220 612 1,305 351 227 172 174 379
Alabama 44 12 4 8 2 9 2 7
Alaska 11 2 6 2 0 0 0 1
Arizona 26 7 9 3 3 0 1 3
Arkansas 6 1 1 1 2 0 1 0
California 620 100 270 55 56 32 41 66
Colorado 27 3 13 2 2 4 1 2
Connecticut 30 7 15 6 2 0 0 0
Delaware 6 2 1 0 0 3 0 0
District of Columbia 12 3 4 3 0 1 0 1
Florida 178 29 67 15 10 13 7 37
Georgia 117 22 48 8 7 8 9 15
Hawaii 18 4 8 2 1 3 0 0
Idaho 2 0 2 0 0 0 0 0
Illinois 166 26 76 14 10 10 5 25
Indiana 11 4 1 1 2 1 0 2
Iowa 4 1 1 0 0 0 2 0
Kansas 22 10 4 1 2 0 0 5
Kentucky 18 2 9 2 2 0 0 3
Louisiana 42 14 11 2 2 2 2 9
Maine 6 1 2 0 1 0 1 1
Maryland 56 16 20 7 5 2 1 5
Massachusetts 91 20 41 11 2 3 4 10
Michigan 80 13 40 9 7 4 1 6
Minnesota 76 16 35 4 6 3 4 8
Mississippi 25 12 7 2 1 1 0 2
Missouri 36 8 8 6 3 1 4 6
Montana 7 3 3 0 1 0 0 0
Nebraska 11 1 3 0 0 0 0 7
Nevada 10 1 3 1 3 1 0 1
New Hampshire 8 0 4 2 1 0 0 1
New Jersey 135 22 63 15 8 7 11 9
New Mexico 11 1 1 1 3 2 2 1
New York 378 53 172 52 29 16 20 36
North Carolina 84 24 26 17 6 4 1 6
North Dakota 3 0 2 0 1 0 0 0
Ohio 95 25 28 10 5 2 8 17
Oklahoma 25 4 11 6 1 1 0 2
Oregon 29 6 12 0 2 1 2 6
Pennsylvania 103 17 44 10 8 3 12 9
Rhode Island 13 2 6 1 1 0 2 1
South Carolina 74 21 33 3 2 2 1 12
South Dakota 3 0 0 0 1 0 1 1
Tennessee 54 11 22 7 6 0 1 7
Texas 271 55 95 40 10 24 19 28
Utah 12 1 8 0 0 1 1 1
Vermont 0 0 0 0 0 0 0 0
Virginia 61 6 32 7 1 3 3 9
Washington 66 14 25 9 8 1 2 7
West Virginia 6 4 0 1 0 0 0 1
Wisconsin 29 6 8 5 2 3 2 3
Wyoming 2 0 1 0 0 1 0 0
American Samoa1 ... ... ... ... ... ... ... ...
Fed. States of Micronesia1    ... ... ... ... ... ... ... ...
Guam1 6 3 0 1 0 1 1 0
N. Mariana Islands1 11 6 3 1 0 0 1 0
Puerto Rico1 24 6 6 1 3 4 1 3
Republic of Palau1 ... ... ... ... ... ... ... ...
U.S. Virgin Islands1 ... ... ... ... ... ... ... ...
1. Not included in U.S. totals.
Ellipses indicate data not available.
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Table 23. Tuberculosis Cases in Residents of Correctional Facilities: 59 Reporting 
Areas, 2000
 Cases with Information on
        Total Residence in Correctional Facilities Percent of Cases in Residents
Reporting Area Cases No. % of Correctional Facilities1
United States 16,377 16,335 99.7 3.6  
Alabama 310 310 100.0 1.9
Alaska 108 107 99.1 0.9
Arizona 261 261 100.0 8.0
Arkansas 199 199 100.0 2.0
California 3,297 3,293 99.9 3.5
Colorado 97 97 100.0 1.0
Connecticut 105 104 99.0 1.0
Delaware 28 27 96.4 0.0
District of Columbia 85 85 100.0 1.2
Florida 1,171 1,171 100.0 5.8
Georgia 703 699 99.4 5.3
Hawaii 136 136 100.0 0.7
Idaho 16 16 100.0 0.0
Illinois 743 738 99.3 2.4
Indiana 145 145 100.0 2.8
Iowa 40 40 100.0 2.5
Kansas 77 76 98.7 1.3
Kentucky 147 146 99.3 0.7
Louisiana 331 327 98.8 4.3
Maine 24 24 100.0 0.0
Maryland 282 282 100.0 1.4
Massachusetts 285 284 99.6 1.1
Michigan 287 287 100.0 2.8
Minnesota 178 178 100.0 2.2
Mississippi 173 168 97.1 0.6
Missouri 211 210 99.5 3.8
Montana 21 21 100.0 0.0
Nebraska 24 24 100.0 0.0
Nevada 96 96 100.0 2.1
New Hampshire 22 22 100.0 0.0
New Jersey 565 565 100.0 0.9
New Mexico 46 46 100.0 6.5
New York State2 412 412 100.0 4.9
New York City 1,332 1,331 99.9 2.0
North Carolina 447 447 100.0 2.0
North Dakota 5 5 100.0 0.0
Ohio 340 340 100.0 4.4
Oklahoma 154 154 100.0 10.4
Oregon 119 119 100.0 2.5
Pennsylvania 383 379 99.0 2.6
Rhode Island 49 49 100.0 0.0
South Carolina 286 286 100.0 9.1
South Dakota 16 16 100.0 0.0
Tennessee 383 383 100.0 4.4
Texas 1,506 1,501 99.7 6.3
Utah 49 49 100.0 4.1
Vermont 4 4 100.0 0.0
Virginia 292 289 99.0 1.4
Washington 258 258 100.0 2.3
West Virginia 33 33 100.0 3.0
Wisconsin 92 92 100.0 1.1
Wyoming 4 4 100.0 25.0
American Samoa3 ... ... ... ...
Fed. States of Micronesia3 ... ... ... ...
Guam3 54 54 100.0 0.0
N. Mariana Islands3 75 75 100.0 0.0
Puerto Rico3 174 174 100.0 2.3
Republic of Palau3 ... ... ... ...
U.S. Virgin Islands3 ... ... ... ...
1. Resident of correctional facility at time of diagnosis.  Percentage for U.S. based on 52 reporting areas (50 states, New York City, and 
the District of Columbia).  Percentages shown only for reporting areas with information reported for >75% of cases.
2. Excludes New York City.
3. Not included in U.S. totals. 
Ellipses indicate data not available.     
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Table 24. Tuberculosis Cases by Homeless Status: 59 Reporting Areas, 2000
 Cases with Information
          Total on Homeless Status Percent of Cases in
Reporting Area Cases No. % Homeless Persons1
United States 16,377 15,926 97.2 6.1  
Alabama 310 310 100.0 3.5
Alaska 108 107 99.1 4.7
Arizona 261 253 96.9 15.0
Arkansas 199 198 99.5 1.5
California 3,297 3,260 98.9 6.9
Colorado 97 97 100.0 8.2
Connecticut 105 102 97.1 3.9
Delaware 28 28 100.0 0.0
District of Columbia 85 85 100.0 11.8
Florida 1,171 1,169 99.8 9.3
Georgia 703 681 96.9 6.0
Hawaii 136 136 100.0 1.5
Idaho 16 15 93.8 6.7
Illinois 743 713 96.0 3.2
Indiana 145 145 100.0 1.4
Iowa 40 39 97.5 10.3
Kansas 77 75 97.4 4.0
Kentucky 147 144 98.0 7.6
Louisiana 331 320 96.7 7.8
Maine 24 24 100.0 4.2
Maryland 282 282 100.0 2.1
Massachusetts 285 285 100.0 6.3
Michigan 287 275 95.8 2.5
Minnesota 178 175 98.3 2.9
Mississippi 173 172 99.4 0.6
Missouri 211 205 97.2 8.3
Montana 21 21 100.0 23.8
Nebraska 24 24 100.0 4.2
Nevada 96 93 96.9 1.1
New Hampshire 22 21 95.5 9.5
New Jersey 565 564 99.8 2.5
New Mexico 46 45 97.8 8.9
New York State2 412 406 98.5 2.0
New York City 1,332 1,072 80.5 5.0
North Carolina 447 445 99.6 6.5
North Dakota 5 5 100.0 0.0
Ohio 340 336 98.8 8.9
Oklahoma 154 154 100.0 11.7
Oregon 119 119 100.0 9.2
Pennsylvania 383 366 95.6 2.5
Rhode Island 49 49 100.0 0.0
South Carolina 286 281 98.3 2.8
South Dakota 16 16 100.0 12.5
Tennessee 383 382 99.7 8.6
Texas 1,506 1,506 100.0 6.7
Utah 49 48 98.0 18.8
Vermont 4 4 100.0 25.0
Virginia 292 289 99.0 5.2
Washington 258 258 100.0 9.3
West Virginia 33 32 97.0 6.3
Wisconsin 92 92 100.0 4.3
Wyoming 4 3 75.0 0.0
American Samoa3 ... ... ... ...
Fed. States of Micronesia3 ... ... ... ...
Guam3 54 53 98.1 1.9
N. Mariana Islands3 75 75 100.0 0.0
Puerto Rico3 174 174 100.0 3.4
Republic of Palau3 ... ... ... ...
U.S. Virgin Islands3 ... ... ... ...
1. Homeless within past 12 months.  Percentage for U.S. based on 52 reporting areas (50 states, New York City, and the District of 
Columbia).  Percentages shown only for reporting areas with information reported for >75% of cases.   
2. Excludes New York City.
3. Not included in U.S. totals.  
Ellipses indicate data not available.
 32
Table 25. Tuberculosis Cases in Residents of Long-term Care Facilities: 59 Reporting
Areas, 2000
            Cases with Information on 
      Total  Residence in Long-term Care Facilities Percent of Cases in Residents
Reporting Area Cases No. %  of Long-term Care Facilities1
United States 16,377 16,329 99.7 2.6
Alabama 310 310 100.0 3.5
Alaska 108 107 99.1 0.0
Arizona 261 261 100.0 2.7
Arkansas 199 198 99.5 4.5
California 3,297 3,292 99.8 2.6
Colorado 97 97 100.0 4.1
Connecticut 105 103 98.1 3.9
Delaware 28 27 96.4 0.0
District of Columbia 85 85 100.0 2.4
Florida 1,171 1,171 100.0 2.7
Georgia 703 699 99.4 3.0
Hawaii 136 136 100.0 0.7
Idaho 16 16 100.0 0.0
Illinois 743 737 99.2 3.8
Indiana 145 145 100.0 3.4
Iowa 40 40 100.0 0.0
Kansas 77 75 97.4 0.0
Kentucky 147 147 100.0 8.2
Louisiana 331 327 98.8 3.7
Maine 24 24 100.0 0.0
Maryland 282 282 100.0 1.8
Massachusetts 285 283 99.3 1.1
Michigan 287 287 100.0 2.4
Minnesota 178 178 100.0 1.1
Mississippi 173 168 97.1 2.4
Missouri 211 210 99.5 4.3
Montana 21 21 100.0 0.0
Nebraska 24 24 100.0 4.2
Nevada 96 96 100.0 1.0
New Hampshire 22 22 100.0 0.0
New Jersey 565 565 100.0 2.5
New Mexico 46 46 100.0 2.2
New York State2 412 412 100.0 3.2
New York City 1,332 1,330 99.8 1.6
North Carolina 447 447 100.0 3.4
North Dakota 5 5 100.0 0.0
Ohio 340 340 100.0 4.1
Oklahoma 154 154 100.0 3.2
Oregon 119 119 100.0 1.7
Pennsylvania 383 377 98.4 4.5
Rhode Island 49 49 100.0 4.1
South Carolina 286 286 100.0 1.0
South Dakota 16 16 100.0 0.0
Tennessee 383 383 100.0 3.9
Texas 1,506 1,502 99.7 2.0
Utah 49 49 100.0 4.1
Vermont 4 4 100.0 0.0
Virginia 292 290 99.3 1.4
Washington 258 258 100.0 2.3
West Virginia 33 33 100.0 3.0
Wisconsin 92 92 100.0 1.1
Wyoming 4 4 100.0 25.0
American Samoa3 ... ... ... ...
Fed. States of Micronesia3 ... ... ... ...
Guam3 54 54 100.0 0.0
N. Mariana Islands3 75 75 100.0 0.0
Puerto Rico3 174 174 100.0 4.6
Republic of Palau3 ... ... ... ...
U.S. Virgin Islands3 ... ... ... ...
1. Resident of long-term care facility at time of diagnosis.  Percentage for U.S. based on 52 reporting areas (50 states, New York City, and the 
District of Columbia).  Percentages shown only for reporting areas with information reported for >75% of cases.  
2. Excludes New York City.
3. Not included in U.S. totals.
Ellipses indicate data not available.   
 33 
    
Table 26. Tuberculosis Cases by Injecting Drug Use: 59 Reporting Areas, 2000
 Cases with Information on
        Total   Injecting Drug Use    Percent of Cases in
Reporting Area Cases No. %        Injecting Drug Users1
United States 16,377 15,495 94.6 2.5
Alabama 310 310 100.0 2.6
Alaska 108 97 89.8 2.1
Arizona 261 249 95.4 4.4
Arkansas 199 197 99.0 0.0
California 3,297 3,148 95.5 2.9
Colorado 97 97 100.0 2.1
Connecticut 105 104 99.0 2.9
Delaware 28 26 92.9 0.0
District of Columbia 85 80 94.1 5.0
Florida 1,171 1,128 96.3 2.5
Georgia 703 602 85.6 1.2
Hawaii 136 132 97.1 0.0
Idaho 16 15 93.8 0.0
Illinois 743 641 86.3 3.4
Indiana 145 145 100.0 3.4
Iowa 40 27 67.5 --
Kansas 77 69 89.6 1.4
Kentucky 147 136 92.5 1.5
Louisiana 331 307 92.7 3.9
Maine 24 24 100.0 0.0
Maryland 282 282 100.0 6.4
Massachusetts 285 279 97.9 0.4
Michigan 287 251 87.5 3.2
Minnesota 178 173 97.2 0.0
Mississippi 173 158 91.3 0.6
Missouri 211 196 92.9 0.0
Montana 21 20 95.2 0.0
Nebraska 24 24 100.0 0.0
Nevada 96 80 83.3 0.0
New Hampshire 22 21 95.5 0.0
New Jersey 565 556 98.4 4.1
New Mexico 46 42 91.3 2.4
New York State2 412 378 91.7 0.5
New York City 1,332 1,238 92.9 4.0
North Carolina 447 436 97.5 1.4
North Dakota 5 5 100.0 0.0
Ohio 340 338 99.4 0.9
Oklahoma 154 152 98.7 3.3
Oregon 119 115 96.6 0.0
Pennsylvania 383 330 86.2 2.4
Rhode Island 49 48 98.0 2.1
South Carolina 286 274 95.8 1.1
South Dakota 16 16 100.0 0.0
Tennessee 383 369 96.3 1.6
Texas 1,506 1,470 97.6 3.0
Utah 49 48 98.0 8.3
Vermont 4 1 25.0 --
Virginia 292 289 99.0 0.3
Washington 258 253 98.1 2.0
West Virginia 33 25 75.8 0.0
Wisconsin 92 91 98.9 4.4
Wyoming 4 3 75.0 0.0
American Samoa3 ... ... ... ...
Fed. States of Micronesia3 ... ... ... ...
Guam3 54 52 96.3 0.0
N. Mariana Islands3 75 75 100.0 0.0
Puerto Rico3 174 173 99.4 19.7
Republic of Palau3 ... ... ... ...
U.S. Virgin Islands3 ... ... ... ...
1. Injecting drug use within past 12 months.  Percentage for U.S. based on 52 reporting areas (50 states, New York City, and the 
District of Columbia).  Percentages shown only for reporting areas with information reported for >75% of cases.
2. Excludes New York City.
3. Not included in U.S. totals.   
Ellipses indicate data not available.   
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Table 27. Tuberculosis Cases by Noninjecting Drug Use: 59 Reporting Areas, 2000
 Cases with Information on
        Total   Noninjecting Drug Use Percent of Cases in
Reporting Area Cases No. %      Noninjecting Drug Users1
United States 16,377 15,454 94.4 7.5  
Alabama 310 310 100.0 7.7
Alaska 108 98 90.7 8.2
Arizona 261 247 94.6 8.1
Arkansas 199 197 99.0 1.0
California 3,297 3,142 95.3 7.2
Colorado 97 97 100.0 3.1
Connecticut 105 104 99.0 8.7
Delaware 28 26 92.9 3.8
District of Columbia 85 79 92.9 15.2
Florida 1,171 1,132 96.7 12.6
Georgia 703 597 84.9 12.9
Hawaii 136 132 97.1 0.0
Idaho 16 14 87.5 0.0
Illinois 743 620 83.4 7.7
Indiana 145 145 100.0 6.9
Iowa 40 26 65.0 --
Kansas 77 70 90.9 10.0
Kentucky 147 139 94.6 6.5
Louisiana 331 307 92.7 16.3
Maine 24 24 100.0 4.2
Maryland 282 281 99.6 5.0
Massachusetts 285 275 96.5 1.5
Michigan 287 252 87.8 5.2
Minnesota 178 174 97.8 3.4
Mississippi 173 155 89.6 8.4
Missouri 211 193 91.5 5.2
Montana 21 20 95.2 5.0
Nebraska 24 20 83.3 0.0
Nevada 96 81 84.4 1.2
New Hampshire 22 21 95.5 0.0
New Jersey 565 556 98.4 5.0
New Mexico 46 41 89.1 4.9
New York State2 412 378 91.7 3.2
New York City 1,332 1,234 92.6 8.6
North Carolina 447 443 99.1 10.6
North Dakota 5 5 100.0 0.0
Ohio 340 336 98.8 7.7
Oklahoma 154 153 99.4 3.9
Oregon 119 116 97.5 9.5
Pennsylvania 383 333 86.9 7.8
Rhode Island 49 48 98.0 0.0
South Carolina 286 271 94.8 10.3
South Dakota 16 16 100.0 0.0
Tennessee 383 370 96.6 7.8
Texas 1,506 1,470 97.6 6.9
Utah 49 48 98.0 6.3
Vermont 4 1 25.0 --
Virginia 292 287 98.3 0.3
Washington 258 252 97.7 3.6
West Virginia 33 25 75.8 4.0
Wisconsin 92 90 97.8 8.9
Wyoming 4 3 75.0 0.0
American Samoa3 ... ... ... ...
Fed. States of Micronesia3 ... ... ... ...
Guam3 54 52 96.3 0.0
N. Mariana Islands3 75 74 98.7 1.4
Puerto Rico3 174 173 99.4 21.4
Republic of Palau3 ... ... ... ...
U.S. Virgin Islands3 ... ... ... ...
1. Noninjecting drug use within past 12 months.  Percentage for U.S. based on 52 reporting areas (50 states, New York City, and the 
District of Columbia).  Percentages shown only for reporting areas with information reported for >75% of cases.   
2. Excludes New York City.
3. Not included in U.S. totals.
Ellipses indicate data not available.  
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Table 28. Tuberculosis Cases by Excess Alcohol Use: 59 Reporting Areas, 2000
    Cases with Information on
        Total         Excess Alcohol Use   Percent of Cases in Persons
Reporting Area Cases No. % with Excess Alcohol Use1
United States 16,377 15,518 94.8 15.0  
Alabama 310 310 100.0 19.7
Alaska 108 102 94.4 28.4
Arizona 261 249 95.4 18.1
Arkansas 199 197 99.0 6.1
California 3,297 3,149 95.5 11.6
Colorado 97 97 100.0 11.3
Connecticut 105 102 97.1 3.9
Delaware 28 26 92.9 11.5
District of Columbia 85 79 92.9 20.3
Florida 1,171 1,136 97.0 23.2
Georgia 703 601 85.5 20.6
Hawaii 136 132 97.1 3.8
Idaho 16 14 87.5 14.3
Illinois 743 624 84.0 14.6
Indiana 145 145 100.0 18.6
Iowa 40 28 70.0 --
Kansas 77 72 93.5 16.7
Kentucky 147 140 95.2 11.4
Louisiana 331 305 92.1 33.1
Maine 24 24 100.0 8.3
Maryland 282 275 97.5 7.3
Massachusetts 285 272 95.4 11.0
Michigan 287 261 90.9 9.2
Minnesota 178 173 97.2 3.5
Mississippi 173 158 91.3 27.8
Missouri 211 197 93.4 14.2
Montana 21 20 95.2 55.0
Nebraska 24 24 100.0 12.5
Nevada 96 81 84.4 12.3
New Hampshire 22 21 95.5 4.8
New Jersey 565 556 98.4 10.4
New Mexico 46 41 89.1 22.0
New York State2 412 374 90.8 7.0
New York City 1,332 1,236 92.8 9.4
North Carolina 447 443 99.1 23.0
North Dakota 5 5 100.0 20.0
Ohio 340 338 99.4 17.5
Oklahoma 154 153 99.4 13.7
Oregon 119 118 99.2 17.8
Pennsylvania 383 334 87.2 11.7 
Rhode Island 49 49 100.0 6.1
South Carolina 286 274 95.8 27.4
South Dakota 16 16 100.0 25.0
Tennessee 383 375 97.9 24.3
Texas 1,506 1,482 98.4 17.8
Utah 49 48 98.0 16.7
Vermont 4 3 75.0 66.7
Virginia 292 286 97.9 4.2
Washington 258 254 98.4 9.4
West Virginia 33 26 78.8 26.9
Wisconsin 92 90 97.8 20.0
Wyoming 4 3 75.0 0.0
American Samoa3 ... ... ... ...
Fed. States of Micronesia3 ... ... ... ...
Guam3 54 53 98.1 0.0
N. Mariana Islands3 75 75 100.0 8.0
Puerto Rico3 174 173 99.4 18.5
Republic of Palau3 ... ... ... ...
U.S. Virgin Islands3 ... ... ... ...
1. Excess alcohol use within past 12 months.  Percentage for U.S. based on 52 reporting areas (50 states, New York City, and the 
District of Columbia).  Percentages shown only for reporting areas with information reported for >75% of cases.    
2. Excludes New York City.
3. Not included in U.S. totals.
Ellipses indicate data not available.
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Table 29. Tuberculosis Cases by Initial Drug Regimen: 59 Reporting Areas, 2000
  Cases    Cases with Information on
         Total Alive at Initial Drug Regimen  Percent of Cases with Initial Drug Regimen1,2
Reporting Area Cases Diagnosis No. % IR IRZ   IRZ,E/S 
United States 16,377 15,947 15,874 99.5 1.9 10.3 78.2
Alabama 310 296 296 100.0 0.3 68.9 27.4
Alaska 108 108 108 100.0 0.0 20.4 75.9
Arizona 261 253 253 100.0 2.4 9.5 75.9
Arkansas 199 188 186 98.9 29.6 49.5 14.0
California 3,297 3,242 3,240 99.9 1.1 5.5 86.3
Colorado 97 93 92 98.9 1.1 6.5 82.6
Connecticut 105 102 101 99.0 3.0 11.9 70.3
Delaware 28 27 27 100.0 7.4 11.1 77.8
District of Columbia 85 80 78 97.5 0.0 2.6 85.9
Florida 1,171 1,123 1,123 100.0 0.8 8.4 83.5
Georgia 703 679 675 99.4 1.2 12.0 74.8
Hawaii 136 134 134 100.0 3.7 14.2 73.9
Idaho 16 16 16 100.0 0.0 18.8 81.3
Illinois 743 728 726 99.7 2.1 7.7 80.6
Indiana 145 138 138 100.0 2.9 18.8 68.8
Iowa 40 40 40 100.0 0.0 30.0 65.0
Kansas 77 76 76 100.0 1.3 18.4 73.7
Kentucky 147 142 142 100.0 1.4 15.5 78.2
Louisiana 331 313 303 96.8 3.3 13.9 75.2
Maine 24 24 24 100.0  0.0 33.3 66.7 
Maryland 282 277 276 99.6 0.4 2.9 92.8
Massachusetts 285 281 279 99.3 1.4 4.3 85.7
Michigan 287 277 277 100.0 7.9 28.9 56.7
Minnesota 178 178 178 100.0 0.6 10.7 73.0
Mississippi 173 171 171 100.0 0.0 15.2 83.0
Missouri 211 204 204 100.0 0.5 3.9 62.7
Montana 21 21 21 100.0 0.0 19.0 71.4
Nebraska 24 23 23 100.0 0.0 34.8 52.2
Nevada 96 91 90 98.9 0.0 8.9 84.4
New Hampshire 22 22 22 100.0 0.0 13.6 86.4
New Jersey 565 544 538 98.9 1.9 9.5 75.5
New  Mexico 46 44 44 100.0 2.3 47.7 45.5
New York State3 412 405 405 100.0 1.2 7.7 85.7
New York City 1,332 1,308 1,308 100.0 1.3 4.2 81.5
North Carolina 447 430 430 100.0 0.5 4.2 88.4
North Dakota 5 5 5 100.0 0.0 20.0 80.0
Ohio 340 330 330 100.0 4.5 20.9 62.1
Oklahoma 154 149 148 99.3 9.5 14.9 56.1
Oregon 119 117 117 100.0 0.0 4.3 85.5
Pennsylvania 383 375 365 97.3 0.3 5.8 75.6
Rhode Island 49 49 49 100.0 0.0 0.0 87.8
South Carolina 286 269 269 100.0 2.2 6.7 73.2
South Dakota 16 14 14 100.0 0.0 42.9 57.1
Tennessee 383 369 369 100.0 3.3 15.4 75.6
Texas 1,506 1,476 1,450 98.2 1.7 7.7 79.0
Utah 49 48 48 100.0 0.0 6.3 85.4
Vermont 4 4 4 100.0 0.0 25.0 75.0
Virginia 292 285 283 99.3 1.4 6.7 85.9
Washington 258 254 254 100.0 2.8 3.9 88.6
West Virginia 33 32 32 100.0 3.1 28.1 53.1
Wisconsin 92 89 89 100.0 2.2 11.2 79.8
Wyoming 4 4 4 100.0 0.0 25.0 50.0
American Samoa4 ... ... ... ... ... ... ...
Fed. States of Micronesia4 ... ... ... ... ... ... ...
Guam4 54 53 53 100.0 0.0 0.0 90.6
N. Mariana Islands4 75 75 75 100.0 0.0 1.3 94.7
Puerto Rico4 174 151 151 100.0 2.0 2.6 90.7
Republic of Palau4 ... ... ... ... ... ... ...
U.S. Virgin Islands4 ... ... ... ... ... ... ...
1. Percentage for U.S. based on 52 reporting areas (50 states, New York City, and the District of Columbia).  Percentages shown
only for reporting areas with information reported for >75% of cases.
2. I=isoniazid; R=rifampin; Z=pyrazinamide; E=ethambutol; S=streptomycin.
3. Excludes New York City.
4. Not included in U.S. totals.
Ellipses indicate data not available.
Note:  Excluding cases with no information on initial drug regimen, 171 (1.1%) were not started on any drugs, 
25 (0.2%) were started on one drug, and 1,314 (8.3%) had an initial multidrug regimen other than IR, IRZ, and IRZ,E/S. 
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Table 30.  Isoniazid-Resistant Tuberculosis Cases with or without Rifampin Resistance:
59 Reporting Areas, 2000
    Total      Cases with Initial
                                                  Culture     Drug Susceptibility Resistance1
 Positive     Testing Performed Isoniazid Isoniazid and Rifampin
Reporting Area Cases No. % No. % No. %
United States 13,035 12,080 92.7 929 7.7 141 1.2
Alabama 271 240 88.6 5 2.1 1 0.4
Alaska 85 80 94.1 5 6.3 0 0.0
Arizona 228 221 96.9 17 7.7 2 0.9
Arkansas 122 113 92.6 2 1.8 0 0.0
California 2,564 2,401 93.6 242 10.1 31 1.3
Colorado 81 81 100.0 7 8.6 3 3.7
Connecticut 90 87 96.7 7 8.0 0 0.0
Delaware 21 17 81.0 2 11.8 1 5.9
District of Columbia 74 70 94.6 7 10.0 2 2.9
Florida 961 911 94.8 85 9.3 7 0.8
Georgia 557 507 91.0 36 7.1 6 1.2
Hawaii 110 102 92.7 9 8.8 3 2.9
Idaho 14 14 100.0 0 0.0 0 0.0
Illinois 623 544 87.3 25 4.6 8 1.5
Indiana 125 122 97.6 3 2.5 0 0.0
Iowa 27 24 88.9 2 8.3 0 0.0
Kansas 55 50 90.9 3 6.0 0 0.0
Kentucky 131 107 81.7 8 7.5 1 0.9
Louisiana 252 229 90.9 10 4.4 2 0.9
Maine 22 21 95.5 2 9.5 0 0.0
Maryland 218 218 100.0 18 8.3 0 0.0
Massachusetts 232 228 98.3 24 10.5 3 1.3
Michigan 215 215 100.0 9 4.2 4 1.9
Minnesota 141 138 97.9 23 16.7 1 0.7
Mississippi 122 121 99.2 15 12.4 2 1.7
Missouri 160 121 75.6 10 8.3 3 2.5
Montana 19 19 100.0 1 5.3 0 0.0
Nebraska 24 23 95.8 1 4.3 0 0.0
Nevada 74 66 89.2 12 18.2 0 0.0
New Hampshire 19 19 100.0 1 5.3 0 0.0
New Jersey 453 446 98.5 49 11.0 8 1.8
New Mexico 42 37 88.1 3 8.1 0 0.0
New York State2 279 278 99.6 16 5.8 3 1.1
New York City 1,063 959 90.2 82 8.6 25 2.6
North Carolina 392 370 94.4 16 4.3 2 0.5
North Dakota 1 1 100.0 0 0.0 0 0.0
Ohio 252 228 90.5 10 4.4 1 0.4
Oklahoma 109 106 97.2 3 2.8 0 0.0
Oregon 94 89 94.7 9 10.1 1 1.1
Pennsylvania 296 253 85.5 26 10.3 4 1.6
Rhode Island 28 27 96.4 1 3.7 0 0.0
South Carolina 204 181 88.7 5 2.8 1 0.6
South Dakota 11 11 100.0 0 0.0 0 0.0
Tennessee 310 283 91.3 7 2.5 1 0.4
Texas 1,235 1,165 94.3 58 5.0 7 0.6 
Utah 45 43 95.6 7 16.3 1 2.3
Vermont 4 4 100.0 0 0.0 0 0.0
Virginia 240 160 66.7 -- -- -- --
Washington 228 224 98.2 25 11.2 4 1.8
West Virginia 32 29 90.6 4 13.8 0 0.0
Wisconsin 76 73 96.1 6 8.2 1 1.4
Wyoming 4 4 100.0 0 0.0 0 0.0
American Samoa3 ... ... ... ... ... ... ...
Fed. States of Micronesia3 ... ... ... ... ... ... ...
Guam3 43 40 93.0 9 22.5 1 2.5
N. Mariana Islands3 52 52 100.0 10 19.2 3 5.8
Puerto Rico3 151 142 94.0 6 4.2 1 0.7
Republic of Palau3 ... ... ... ... ... ... ...
U.S. Virgin Islands3 ... ... ... ... ... ... ...
1. Isolates may be resistant to other drugs.  Percentage for U.S. based on 52 reporting areas (50 states, New York City, and the District of 
Columbia).  Percentages shown only for reporting areas with information reported for >75% of cases. 
2. Excludes New York City.
3. Not included in U.S. totals.   
Ellipses indicate data not available.   
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Table 31. Tuberculosis Cases, Aged 25 - 44, by HIV Status: 59 Reporting Areas, 2000
 Cases with Information
     Total on HIV Status1   Percent of Cases in
Reporting Area Cases No. % HIV-Positive Persons2
United States 5,588 3,246 58.1 --
Alabama 91 84 92.3 21.4
Alaska 34 19 55.9 --
Arizona 91 66 72.5 --
Arkansas 41 38 92.7 10.5
California 1,059 0 0.0 --
Colorado 31 28 90.3 21.4
Connecticut 43 31 72.1 --
Delaware 8 3 37.5 --
District of Columbia 31 29 93.5 34.5
Florida 444 397 89.4 38.5
Georgia 225 189 84.0 27.0
Hawaii 35 2 5.7 --
Idaho 4 3 75.0 0.0
Illinois 255 127 49.8 --
Indiana 40 24 60.0 --
Iowa 20 6 30.0 --
Kansas 28 22 78.6 4.5
Kentucky 32 17 53.1 --
Louisiana 102 86 84.3 20.9
Maine 4 2 50.0 --
Maryland 98 73 74.5 --
Massachusetts 110 53 48.2 --
Michigan 92 49 53.3 --
Minnesota 65 53 81.5 3.8
Mississippi 55 35 63.6 --
Missouri 66 43 65.2 --
Montana 9 6 66.7 --
Nebraska 10 6 60.0 --
Nevada 37 32 86.5 12.5
New Hampshire 10 4 40.0 --
New Jersey 211 107 50.7 --
New Mexico 5 4 80.0 0.0
New York State3 133 89 66.9 --
New York City 565 417 73.8 --
North Carolina 160 141 88.1 26.2
North Dakota 0 0 0.0 --
Ohio 99 67 67.7 --
Oklahoma 53 45 84.9 8.9
Oregon 52 46 88.5 2.2
Pennsylvania 123 57 46.3 --
Rhode Island 17 8 47.1 --
South Carolina 98 94 95.9 30.9
South Dakota 2 2 100.0 0.0
Tennessee 115 98 85.2 21.4
Texas 529 376 71.1 --
Utah 15 11 73.3 --
Vermont 1 1 100.0 0.0
Virginia 107 63 58.9 --
Washington 96 64 66.7 --
West Virginia 4 2 50.0 --
Wisconsin 32 27 84.4 7.4
Wyoming 1 0 0.0 --
American Samoa4 ... ... ... ...
Fed. States of Micronesia4 ... ... ... ...
Guam4 15 1 6.7 --
N. Mariana Islands4 41 39 95.1 2.6
Puerto Rico4 63 55 87.3 60.0
Republic of Palau4 ... ... ... ...
U.S. Virgin Islands4 ... ... ... ...
1. Includes only those cases with negative, positive, and indeterminate HIV test results.                             
2. Percentages shown only for reporting areas with information reported for >75% of cases.
3. Excludes New York City.
4. Not included in U.S. totals.   
Ellipses indicate data not available.
 39  
Table 32. Tuberculosis Cases by Occupation: 59 Reporting Areas, 2000
 Cases with Percent of Cases by Occupation1
  Information Unemployed Health
   Total on Occupation Past Care  Correctional Migrant       Other          Multiple
Reporting Area Cases No. % 24 Mos.  Worker    Employee Worker  Occupation    Occupations
United States 16,377 15,242 93.1 56.8 2.8 0.1 1.2 39.0 0.1
Alabama 310 308 99.4 63.6 1.9 0.0 0.3 34.1 0.0
Alaska 108 64 59.3 -- -- -- -- -- --
Arizona 261 244 93.5 58.2 2.0 0.0 3.7 35.7 0.4
Arkansas 199 197 99.0 90.4 2.0 0.5 0.0 7.1 0.0
California 3,297 3,134 95.1 57.8 2.3 0.0 1.9 38.0 0.0
Colorado 97 97 100.0 50.5 6.2 0.0 1.0 41.2 1.0
Connecticut 105 103 98.1 48.5 8.7 0.0 0.0 42.7 0.0
Delaware 28 27 96.4 37.0 0.0 0.0 3.7 59.3 0.0
District of Columbia 85 84 98.8 75.0 4.8 0.0 0.0 20.2 0.0
Florida 1,171 1,143 97.6 45.5 2.4 0.0 2.4 49.3 0.3
Georgia 703 568 80.8 53.0 2.5 0.2 1.4 43.0 0.0
Hawaii 136 110 80.9 60.9 2.7 0.0 0.0 36.4 0.0
Idaho 16 15 93.8 46.7 6.7 0.0 0.0 46.7 0.0
Illinois 743 605 81.4 54.9 4.5 0.0 0.5 40.0 0.2
Indiana 145 143 98.6 62.9 2.8 0.0 2.1 32.2 0.0
Iowa 40 37 92.5 29.7 2.7 0.0 2.7 64.9 0.0
Kansas 77 71 92.2 43.7 2.8 0.0 0.0 53.5 0.0
Kentucky 147 143 97.3 73.4 2.1 0.0 3.5 21.0 0.0
Louisiana 331 308 93.1 63.3 0.6 0.3 0.0 35.7 0.0
Maine 24 23 95.8 65.2 0.0 0.0 4.3 30.4 0.0
Maryland 282 278 98.6 50.0 4.7 0.0 0.0 45.0 0.4
Massachusetts 285 269 94.4 52.8 4.1 0.0 0.4 42.8 0.0
Michigan 287 234 81.5 56.8 6.0 0.0 0.4 36.8 0.0
Minnesota 178 176 98.9 52.3 1.7 0.0 1.1 44.3 0.6
Mississippi 173 163 94.2 57.7 1.2 0.0 0.6 39.9 0.6
Missouri 211 197 93.4 64.0 1.5 0.5 0.0 34.0 0.0
Montana 21 21 100.0 57.1 0.0 0.0 0.0 42.9 0.0
Nebraska 24 24 100.0 45.8 0.0 0.0 0.0 54.2 0.0
Nevada 96 93 96.9 37.6 2.2 0.0 0.0 60.2 0.0
New Hampshire 22 21 95.5 19.0 4.8 0.0 0.0 76.2 0.0
New Jersey 565 560 99.1 58.0 2.3 0.4 0.5 38.4 0.4
New Mexico 46 38 82.6 78.9 0.0 0.0 0.0 21.1 0.0
New York State2 412 372 90.3 56.5 4.3 0.0 1.1 38.2 0.0
New York City 1,332 1,216 91.3 65.4 3.3 0.0 0.0 31.2 0.2
North Carolina 447 435 97.3 48.5 2.3 0.5 3.2 45.3 0.2
North Dakota 5 5 100.0 60.0 0.0 0.0 0.0 40.0 0.0
Ohio 340 326 95.9 58.6 3.4 0.0 0.0 38.0 0.0
Oklahoma 154 149 96.8 47.0 2.0 0.0 0.0 51.0 0.0
Oregon 119 116 97.5 47.4 0.9 0.0 5.2 46.6 0.0
Pennsylvania 383 297 77.5 58.6 3.4 0.0 0.3 37.4 0.3
Rhode Island 49 49 100.0 61.2 4.1 0.0 0.0 34.7 0.0
South Carolina 286 255 89.2 60.8 1.6 0.4 1.6 35.7 0.0
South Dakota 16 16 100.0 87.5 0.0 0.0 0.0 12.5 0.0
Tennessee 383 370 96.6 58.1 1.6 0.5 1.4 38.4 0.0
Texas 1,506 1,433 95.2 59.7 3.1 0.2 1.0 35.8 0.2
Utah 49 47 95.9 48.9 2.1 0.0 0.0 48.9 0.0
Vermont 4 4 100.0 25.0 0.0 0.0 0.0 75.0 0.0
Virginia 292 280 95.9 40.0 3.9 0.4 1.1 54.6 0.0
Washington 258 249 96.5 43.4 3.6 0.0 3.2 49.4 0.4
West Virginia 33 31 93.9 71.0 6.5 0.0 0.0 22.6 0.0
Wisconsin 92 91 98.9 46.2 3.3 0.0 1.1 49.5 0.0
Wyoming 4 3 75.0 33.3 0.0 0.0 0.0 66.7 0.0
American Samoa3 ... ... ... ... ... ... ... ... ...
Fed. States of Micronesia3 ... ... ... ... ... ... ... ... ...
Guam3 54 35 64.8 -- -- -- -- -- --
N. Mariana Islands3 75 75 100.0 13.3 0.0 0.0 1.3 85.3 0.0
Puerto Rico3 174 172 98.9 84.9 1.2 0.6 0.0 13.4 0.0
Republic of Palau3 ... ... ... ... ... ... ... ... ...
U.S. Virgin Islands3 ... ... ... ... ... ... ... ... ...
1. Occupation within past 24 months.  Percentage for U.S. based on 52 reporting areas (50 states, New York City, and the District of Columbia). 
Percentages shown only for reporting areas with information reported for >75% of cases.  
2. Excludes New York City.
3. Not included in U.S. totals.   
Ellipses indicate data not available.   
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Table 33.  Tuberculosis Cases by Type of Health Care Provider: 59 Reporting Areas, 1998
 Percent of Cases by Type of Health Care Provider1
 Cases  Cases with Information on Both
    Total Alive at Type of Health Care Provider        Health Health Department
Reporting Area Cases Diagnosis No. %     Department Private/Other and Private/Other
United States 18,295 17,752 17,264 97.3 44.4 27.5 28.0
Alabama 381 363 362 99.7 63.0 9.4 27.6
Alaska 55 55 54 98.2 18.5 3.7 77.8
Arizona 254 244 244 100.0 55.3 28.7 16.0
Arkansas 171 165 164 99.4 56.7 3.0 40.2
California 3,851 3,765 3,737 99.3 50.3 31.7 18.1
Colorado 79 75 75 100.0 66.7 18.7 14.7
Connecticut 127 122 122 100.0 13.1 84.4 2.5
Delaware 36 35 35 100.0 60.0 17.1 22.9
District of Columbia 107 101 101 100.0 40.6 42.6 16.8
Florida 1,295 1,258 1,253 99.6 50.8 17.0 32.2
Georgia 630 612 609 99.5 46.8 14.3 38.9
Hawaii 181 173 173 100.0 39.3 20.8 39.9
Idaho 14 14 13 92.9 30.8 23.1 46.2
Illinois 842 826 811 98.2 45.0 37.7 17.3
Indiana 188 181 180 99.4 10.6 17.8 71.7
Iowa 55 51 50 98.0 14.0 14.0 72.0
Kansas 56 53 53 100.0 84.9 1.9 13.2
Kentucky 179 169 162 95.9 43.8 19.1 37.0
Louisiana 379 366 215 58.7 -- -- --
Maine 13 13 13 100.0 23.1 46.2 30.8
Maryland 324 316 315 99.7 75.6 11.7 12.7
Massachusetts 280 271 270 99.6 51.9 17.0 31.1
Michigan 383 368 367 99.7 44.4 32.4 23.2
Minnesota 161 155 155 100.0 51.6 47.1 1.3
Mississippi 225  222 222 100.0 32.9 4.1 63.1 
Missouri 184  179 174 97.2 15.5 25.9 58.6
Montana 20  20 20 100.0 35.0 25.0 40.0
Nebraska 31  30 30 100.0 0.0 90.0 10.0
Nevada 128  123 118 95.9 88.1 5.9 5.9
New Hampshire 14 13 13 100.0 0.0 0.0 100.0
New Jersey 639 622 610 98.1 48.0 47.4 4.6
New Mexico 68 64 64 100.0 57.8 10.9 31.3
New York State2 438 422 401 95.0 45.6 34.2 20.2
New York City 1,537 1,508 1,470 97.5 32.4 22.0 45.6
North Carolina 498 478 447 93.5 31.8 17.2 51.0
North Dakota 10 9 9 100.0 0.0 22.2 77.8
Ohio 230 221 220 99.5 50.5 37.3 12.3
Oklahoma 198 191 188 98.4 97.3 2.7 0.0
Oregon 156 151 140 92.7 50.0 16.4 33.6
Pennsylvania 448 434 361 83.2 57.3 21.3 21.3
Rhode Island 63 60 60 100.0 93.3 5.0 1.7
South Carolina 286 269 263 97.8 76.8 8.4 14.8
South Dakota 23 20 20 100.0 55.0 0.0 45.0
Tennessee 439 422 416 98.6 26.2 12.3 61.5
Texas 1,803 1,747 1,695 97.0 22.0 49.6 28.4
Utah 52 52 52 100.0 57.7 1.9 40.4
Vermont 5 5 5 100.0 40.0 20.0 40.0
Virginia 339 329 329 100.0 42.2 51.4 6.4
Washington 265 260 257 98.8 47.1 20.2 32.7
West Virginia 42 41 39 95.1 10.3 43.6 46.2
Wisconsin 109 105 104 99.0 8.7 4.8 86.5
Wyoming 4 4 4 100.0 0.0 0.0 100.0
American Samoa3 ... ... ... ... ... ... ...
Fed. States of Micronesia3 ... ... ... ... ... ... ...
Guam3 89 89 89 100.0 98.9 0.0 1.1
N. Mariana Islands3 110 110 106 96.4 100.0 0.0 0.0
Puerto Rico3 201 176 171 97.2 84.8 11.7 3.5
Republic of Palau3 ... ... ... ... ... ... ...
U.S. Virgin Islands3 ... ... ... ... ... ... ...
1. Health Department: All outpatient care provided by the state or local health department; Private/Other: All care (except contact investigation and 
dispensing of medication) provided by non-health department providers; Both Health Department and Private/Other: Both sectors involved in the care 
of the patient.  Percentage for U.S. based on 52 reporting areas (50 states, New York City, and the District of Columbia).  Percentages shown only for 
reporting areas with information reported for >75% of cases. 
2. Excludes New York City.
3. Not included in U.S. totals.   
Ellipses indicate data not available.
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 Table 34. Tuberculosis Cases by Directly Observed Therapy: 59 Reporting Areas, 1998
Percent of Cases by
 Cases with Initial Cases with Information on Administration of Therapy2
    Total      Drug Regimen Directly Observed Therapy DOT     Both DOT and
Reporting Area Cases       Prescribed1 No. %   Only  Self-Administered
United States 18,295 17,585 17,003 96.7 51.7 22.4  
Alabama 381 363 362 99.7 72.1 26.5
Alaska 55 55 54 98.2 79.6 18.5
Arizona 254 240 239 99.6 64.4 12.1
Arkansas 171 163 161 98.8 44.1 9.9
California 3,851 3,727 3,619 97.1 40.7 25.0
Colorado 79 74 74 100.0 83.8 6.8
Connecticut 127 121 121 100.0 62.0 2.5
Delaware 36 35 35 100.0 62.9 25.7
District of Columbia 107 101 101 100.0 36.6 25.7
Florida 1,295 1,240 1,236 99.7 41.9 40.6
Georgia 630 608 598 98.4 51.2 33.4
Hawaii 181 173 173 100.0 53.2 17.3
Idaho 14 14 14 100.0 42.9 42.9
Illinois 842 805 794 98.6 49.7 12.3
Indiana 188 180 179 99.4 60.9 11.2
Iowa 55 48 48 100.0 29.2 43.8
Kansas 56 53 53 100.0 86.8 7.5
Kentucky 179 169 163 96.4 53.4 23.9
Louisiana 379 360 212 58.9 -- --
Maine 13 13 13 100.0 46.2 7.7
Maryland 324 316 315 99.7 89.5 6.0
Massachusetts 280 270 270 100.0 33.3 17.8
Michigan 383 367 366 99.7 17.8 31.4
Minnesota 161 154 150 97.4 45.3 30.7
Mississippi 225 222 222 100.0 99.5 0.5
Missouri 184 177 169 95.5 58.6 27.2
Montana 20 20 20 100.0 60.0 5.0
Nebraska 31 30 30 100.0 36.7 3.3
Nevada 128 121 117 96.7 29.9 13.7
New Hampshire 14 13 13 100.0 53.8 23.1
New Jersey 639 619 610 98.5 11.3 44.1
New Mexico 68 64 64 100.0 48.4 15.6
New York State3 438 421 415 98.6 62.9 24.8
New York City 1,537 1,490 1,446 97.0 53.3 13.0
North Carolina 498 478 476 99.6 69.5 20.8
North Dakota 10 9 9 100.0 33.3 66.7
Ohio 230 221 220 99.5 54.5 19.1
Oklahoma 198 191 190 99.5 58.4 15.3
Oregon 156 150 145 96.7 57.9 23.4
Pennsylvania 448 431 361 83.8 46.8 17.7
Rhode Island 63 60 60 100.0 93.3 5.0
South Carolina 286 269 264 98.1 88.6 3.0
South Dakota 23 20 20 100.0 85.0 10.0
Tennessee 439 422 412 97.6 31.8 47.1
Texas 1,803 1,725 1,611 93.4 71.3 20.6
Utah 52 51 51 100.0 54.9 11.8
Vermont 5 5 5 100.0 40.0 40.0
Virginia 339 328 328 100.0 51.5 10.1
Washington 265 253 251 99.2 65.7 10.8
West Virginia 42 38 36 94.7 16.7 5.6
Wisconsin 109 104 104 100.0 53.8 14.4
Wyoming 4 4 4 100.0 50.0 0.0
American Samoa4 ... ... ... ... ... ...
Fed. States of Micronesia4 ... ... ... ... ... ...
Guam4 89 89 89 100.0 0.0 98.9
N. Mariana Islands4 110 109 106 97.2 97.2 2.8
Puerto Rico4 201 176 170 96.6 69.4 3.5
Republic of Palau4 ... ... ... ... ... ...
U.S. Virgin Islands4 ... ... ... ... ... ...
1. Includes patients alive at diagnosis with an initial drug regimen of one or more drugs prescribed.  
2. Percentage for U.S. based on 52 reporting areas (50 states, New York City, and the District of Columbia).  Percentages shown only for 
reporting areas with information reported for >75% of cases.  
3. Excludes New York City.
4. Not included in U.S. totals.   
Ellipses indicate data not available.
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Table 35.  Completion of Tuberculosis Therapy (COT): 59 Reporting Areas, 1998
    Total   Therapy <1 Year Indicated1 Therapy >1 Year Indicated2     Overall
Reporting Area Cases No.3 COT <1 Year(%)    COT(%) No.3     COT(%) No.3    COT(%)
United States 18,295 15,807 79.1 90.7 224 71.0 16,031 90.4  
Alabama 381 330 83.9 93.9 3 100.0 333 94.0
Alaska 55 54 85.2 90.7 0 ... 54 90.7
Arizona 254 211 84.4 95.7 5 80.0 216 95.4
Arkansas 171 140 85.0 93.6 0 ... 140 93.6
California 3,851 3,402 78.8 92.2 55 85.5 3,457 92.0
Colorado 79 64 96.9 96.9 1 100.0 65 96.9
Connecticut 127 109 82.6 89.0 2 100.0 111 89.2
Delaware 36 29 75.9 93.1 0 ... 29 93.1
District of Columbia 107 90 73.3 85.6 4 100.0 94 86.2
Florida 1,295 1,098 81.4 93.7 15 73.3 1,113 93.4
Georgia 630 556 79.9 90.6 4 75.0 560 90.5
Hawaii 181 155 84.5 92.3 0 ... 155 92.3
Idaho 14 14 64.3 85.7 0 ... 14 85.7
Illinois 842 722 78.3 89.3 12 75.0 734 89.1
Indiana 188 154 83.1 94.8 3 66.7 157 94.3
Iowa 55 44 75.0 95.5 0 ... 44 95.5
Kansas 56 49 93.9 100.0 1 100.0 50 100.0
Kentucky 179 146 80.1 90.4 1 100.0 147 90.5
Louisiana 379 333 -- -- 3 -- 336 --
Maine 13 10 70.0 100.0 0 ... 10 100.0
Maryland 324 278 85.3 94.2 5 60.0 283 93.6
Massachusetts 280 252 81.7 92.9 1 100.0 253 92.9
Michigan 383 323 84.2 92.3 5 60.0 328 91.8
Minnesota 161 146 82.2 93.2 2 100.0 148 93.2
Mississippi 225 198 89.9 97.5 1 100.0 199 97.5
Missouri 184 150 77.3 87.3 1 100.0 151 87.4
Montana 20 14 100.0 100.0 0 ... 14 100.0
Nebraska 31 26 69.2 76.9 2 100.0 28 78.6
Nevada 128 114 83.3 91.2 1 100.0 115 91.3
New Hampshire 14 13 100.0 100.0 0 ... 13 100.0
New Jersey 639 546 74.4 91.2 12 91.7 558 91.2
New Mexico 68 58 87.9 98.3 1 100.0 59 98.3
New York State4 438 384 70.6 85.4 4 50.0 388 85.1
New York City 1,537 1,313 80.7 90.4 35 25.7 1,348 88.7
North Carolina 498 424 91.7 98.3 4 75.0 428 98.1
North Dakota 10 8 62.5 100.0 1 100.0 9 100.0
Ohio 230 194 77.3 91.8 4 75.0 198 91.4
Oklahoma 198 168 78.6 88.7 1 0.0 169 88.2
Oregon 156 138 77.5 85.5 3 66.7 141 85.1
Pennsylvania 448 382 -- -- 4 -- 386 --
Rhode Island 63 58 82.8 96.6 1 100.0 59 96.6
South Carolina 286 240 74.2 93.8 0 ... 240 93.8
South Dakota 23 13 92.3 100.0 0 ... 13 100.0
Tennessee 439 372 81.5 94.9 4 100.0 376 94.9
Texas 1,803 1,571 77.3 89.4 19 63.2 1,590 89.1
Utah 52 48 75.0 95.8 0 ... 48 95.8
Vermont 5 4 100.0 100.0 0 ... 4 100.0
Virginia 339 303 83.5 92.4 2 100.0 305 92.5
Washington 265 235 84.3 94.0 2 50.0 237 93.7
West Virginia 42 30 66.7 83.3 0 ... 30 83.3
Wisconsin 109 90 83.3 96.7 0 ... 90 96.7
Wyoming 4 4 100.0 100.0 0 ... 4 100.0
American Samoa5 ... ... ... ... ... ... ... ...
Fed. States of Micronesia5 ... ... ... ... ... ... ... ...
Guam5 89 83 88.0 89.2 1 0.0 84 88.1
N. Mariana Islands5 110 107 79.4 80.4 1 0.0 108 79.6
Puerto Rico5 201 150 80.7 91.3 4 75.0 154 90.9
Republic of Palau5 ... ... ... ... ... ... ... ...
U.S. Virgin Islands5 ... ... ... ... ... ... ... ...
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1. Initial isolate susceptible to rifampin (n=12,118) or susceptibility unknown (n=316); culture-negative (n=2,562); culture status unknown (n=811); age 
unknown (n=0). 
2. Initial isolate rifampin resistant, or pediatric (aged <15) case with meningeal, bone or joint, or miliary disease.  
3. Number of cases in persons alive at diagnosis, with initial drug regimen of one or more drugs prescribed, who did not die during therapy.  Percentage for 
U.S. based on 52 reporting areas (50 states, New York City, and the District of Columbia).  Percentages shown only for reporting areas with information on 
reason therapy stopped for >90% of cases.  
4. Excludes New York City.
5. Not included in U.S. totals. 
Ellipses indicate data not available.
Note: See Technical Notes (Appendix A) for description of COT calculation.
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 Table 36. Tuberculosis Cases in Selected Cities: 2000 and 1999     
 Cases1
City 2000 1999
Albuquerque, NM 7 13
Anaheim, Calif 38 37
Arlington, Tex 20 19
Atlanta, Ga 127 112
Austin, Tex 65 70
Baltimore, Md 67 77
Birmingham, Ala 50 51
Boston, Mass 82 77
Buffalo, NY 10 9
Charlotte, NC 64 73
Chicago, Ill 400 463
Cincinnati, Ohio 22 20
Cleveland, Ohio 68 78
Colorado Springs, Colo 6 9
Columbus, Ohio 71 52
Corpus Christi, Tex 23 26
Dallas, Tex 142 162
Denver, Colo 40 39
Detroit, Mich 111 134
El Paso, Tex 52 60
Fort Worth, Tex 62 74
Fresno, Calif 68 77
Honolulu, Hawaii 59 88
Houston, Tex 364 416
Indianapolis, Ind 37 35
Jacksonville, Fla 102 89
Kansas City, Mo 42 42
Las Vegas, Nev 65 56
Long Beach, Calif 63 88
Los Angeles, Calif 443 504
Louisville, Ky 27 30
Memphis, Tenn 78 94
Mesa, Ariz 14 9
Miami, Fla 98 92
Milwaukee, Wis 37 46
Minneapolis, Minn 80 85
Nashville, Tenn 70 50
Newark, NJ 73 58
New Orleans, La 97 67
New York, NY 1,332 1,460
Norfolk, Va 12 20
Oakland, Calif 101 114
Oklahoma City, Okla 44 53
Omaha, Neb 9 4
Philadelphia, Pa 159 182
Phoenix, Ariz 104 96
Pittsburgh, Pa 9 17
Portland, Ore 43 53
Sacramento, Calif 93 72
St. Louis, Mo 47 41
St. Paul, Minn 19 22
San Antonio, Tex 84 91
San Diego, Calif 169 162
San Francisco, Calif 170 235
San Jose, Calif 150 176
Santa Ana, Calif 49 47
Seattle, Wash 77 74
Tampa, Fla 64 84
Toledo, Ohio 6 6
Tucson, Ariz 22 38
Tulsa, Okla 16 37
Virginia Beach, Va 14 15
Washington, DC 85 70
Wichita, Kan 25 25
Total - 64 Cities 6,247 6,775
San Juan, Puerto Rico 32 31
1. Case counts are based on verified cases in persons residing within city limits.  Residence within 
city limits was determined by the health department. 
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Table 37. Tuberculosis Cases and Case Rates per 100,000 Population:  Metropolitan 
Statistical Areas with >500,000 Population, 2000 and 1999
      April 1, 2000
Metropolitan Cases Case Rates         Census
Statistical Area 2000 1999 2000 1999         Population
Akron, Ohio 16 14 2.3 2.0 694,960
Albany-Schenectady, NY 29 19 3.3 2.2 875,583
Albuquerque, NM 6 16 0.8 2.4 712,738
Allentown, Pa 15 17 2.4 2.7 637,958
Ann Arbor, Mich 14 15 2.4 2.7 578,736
Atlanta, Ga 403 343 9.8 8.9 4,112,198
Austin, Tex 81 90 6.5 7.9 1,249,763
Bakersfield, Calif 49 62 7.4 9.6 661,645
Baltimore, Md 119 134 4.7 5.4 2,552,994
Baton Rouge, La 22 39 3.6 6.7 602,894
Bergen-Passaic, NJ 78 104 5.7 7.7 1,373,167
Birmingham, Ala 80 77 8.7 8.4 921,106
Boston, Mass 276 267 4.6 4.5 6,057,826
Buffalo, NY 20 25 1.7 2.2 1,170,111
Charleston, SC 38 28 6.9 5.1 549,033
Charlotte, NC 104 103 6.9 7.3 1,499,293
Chicago, Ill 657 717 7.9 9.0 8,272,768
Cincinnati, Ohio 44 42 2.7 2.6 1,646,395
Cleveland, Ohio 108 109 4.8 4.9 2,250,871
Colorado Springs, Colo 7 ... 1.4 ... 516,929
Columbia, SC 27 30 5.0 5.8 536,691
Columbus, Ohio 85 62 5.5 4.2 1,540,157
Dallas, Tex 229 255 6.5 7.8 3,519,176
Dayton, Ohio 16 16 1.7 1.7 950,558
Denver, Colo 63 65 3.0 3.3 2,109,282
Detroit, Mich 194 231 4.4 5.2 4,441,551
El Paso, Tex 56 61 8.2 8.7 679,622
Fort Lauderdale, Fla 102 143 6.3 9.3 1,623,018
Fort Wayne, Ind 12 ... 2.4 ... 502,141
Fort Worth, Tex 101 117 5.9 7.2 1,702,625
Fresno, Calif 105 110 11.4 12.5 922,516
Gary, Ind 24 22 3.8 3.5 631,362
Grand Rapids, Mich 33 32 3.0 3.0 1,088,514
Greensboro, NC 41 68 3.3 5.8 1,251,509
Greenville, SC 42 34 4.4 3.7 962,441
Harrisburg, Pa 21 11 3.3 1.8 629,401
Hartford, Conn 29 48 2.5 4.3 1,148,618
Honolulu, Hawaii 108 147 12.3 17.0 876,156
Houston, Tex 432 482 10.3 12.0 4,177,646
Indianapolis, Ind 48 50 3.0 3.3 1,607,486
Jacksonville, Fla 125 105 11.4 9.9 1,100,491
Jersey City, NJ 85 84 14.0 15.2 608,975
Kansas City, Mo 73 63 4.1 3.6 1,776,062
Knoxville, Tenn 28 42 4.1 6.2 687,249
Las Vegas, Nev 88 68 5.6 4.9 1,563,282
Little Rock, Ark 21 24 3.6 4.3 583,845
Los Angeles, Calif 1,140 1,265 12.0 13.6 9,519,338
Louisville, Ky 36 47 3.5 4.7 1,025,598
McAllen, Tex 80 75 14.0 14.0 569,463
Memphis, Tenn 92 97 8.1 8.8 1,135,614
Miami, Fla 280 273 12.4 12.5 2,253,362
Middlesex, NJ 84 82 7.2 7.3 1,169,641
Milwaukee, Wis 46 59 3.1 4.0 1,500,741
Minneapolis-St. Paul, Minn 137 161 4.6 5.6 2,968,806
Mobile, Ala 31 34 5.7 6.3 540,258
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Table 37. (Cont'd) Tuberculosis Cases and Case Rates per 100,000 Population: Metropolitan 
Statistical Areas with >500,000 Population, 2000 and 1999
     April 1, 2000
Metropolitan Cases Case Rates          Census
Statistical Area 2000 1999 2000 1999       Population
Monmouth-Ocean City, NJ 41 33 3.6 3.0 1,126,217
Nashville, Tenn 96 85 7.8 7.3 1,231,311
Nassau-Suffolk, NY 137 129 5.0 4.8 2,753,913
New Haven, Conn 54 65 3.2 4.0 1,706,575
New Orleans, La 142 122 10.6 9.3 1,337,726
New York, NY 1,427 1,540 15.3 17.7 9,314,235
Newark, NJ 194 181 9.5 9.3 2,032,989
Norfolk, Va 57 62 3.6 4.0 1,569,541
Oakland, Calif 309 338 12.9 14.4 2,392,557
Oklahoma City, Okla 64 79 5.9 7.6 1,083,346
Omaha, Neb 12 9 1.7 1.3 716,998
Orange County, Calif 246 245 8.6 8.9 2,846,289
Orlando, Fla 140 154 8.5 10.0 1,644,561
Philadelphia, Pa 263 299 5.2 6.0 5,100,931
Phoenix, Ariz 172 159 5.3 5.3 3,251,876
Pittsburgh, Pa 38 62 1.6 2.7 2,358,695
Portland, Ore 83 87 4.3 4.7 1,918,009
Providence, RI 49 52 5.1 5.7 962,886
Raleigh-Durham, NC 84 79 7.1 7.1 1,187,941
Richmond, Va 16 28 1.6 2.9 996,512
Riverside-San Bernardino, Calif 175 192 5.4 6.0 3,254,821
Rochester, NY 40 30 3.6 2.8 1,098,201
Sacramento, Calif 126 101 7.7 6.4 1,628,197
St. Louis, Mo 107 98 4.1 3.8 2,603,607
Salt Lake City, Utah 41 32 3.1 2.5 1,333,914
San Antonio, Tex 99 100 6.2 6.4 1,592,383
San Diego, Calif 296 297 10.5 10.5 2,813,833
San Francisco, Calif 227 307 13.1 18.2 1,731,183
San Jose, Calif 235 244 14.0 14.8 1,682,585
Sarasota, Fla 25 19 4.2 3.5 589,959
Scranton, Pa 15 23 2.4 3.8 624,776
Seattle, Wash 148 127 6.1 5.4 2,414,616
Springfield, Mass 16 12 2.6 2.0 608,479
Stockton, Calif 72 74 12.8 13.1 563,598
Syracuse, NY 26 37 3.6 5.0 732,117
Tacoma, Wash 34 43 4.9 6.2 700,820
Tampa-St. Petersburg, Fla 127 156 5.3 6.8 2,395,997
Toledo, Ohio 9 10 1.5 1.6 618,203
Tucson, Ariz 23 46 2.7 5.7 843,746
Tulsa, Okla 24 46 3.0 5.9 803,235
Vallejo, Calif 30 35 5.8 6.9 518,821
Ventura, Calif 44 62 5.8 8.3 753,197
Washington, DC 385 366 7.8 7.7 4,923,153
West Palm Beach, Fla 76 108 6.7 10.3 1,131,184
Wichita, Kan 29 29 5.3 5.3 545,220
Wilmington, Del 17 15 2.9 2.6 586,216
Youngstown, Ohio 17 10 2.9 1.7 594,746
Total - 102 Areas 12,367 13,111 6.9 7.7 178,060,078
San Juan, Puerto Rico 68 79 3.5 3.9 1,967,627
Note:  In 2000, there were 102 metropolitan statistical areas with populations of 500,000 or more.  In 1999, Colorado Springs, Colorado 
and Fort Wayne, Indiana metropolitan statistical areas had populations under 500,000.
Ellipses indicate data not applicable.
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Table 38. Tuberculosis Cases by Form of Disease: Metropolitan Statistical Areas with 
>500,000 Population, 2000 
Cases with Both Pulmonary and 
Extrapulmonary Disease 
Metropolitan Total Pulmonary1  Extrapulmonary2 Total
3 Miliary 
Statistical Area Cases No. % No. % No. % No. 
Akron, Ohio 16 9 56.3 7 43.8 0 0.0 0 
Albany-Schenectady, NY 29 18 62.1 8 27.6 3 10.3 0 
Albuquerque, NM 6 5 83.3 1 16.7 0 0.0 0 
Allentown, Pa 15 8 53.3 5 33.3 2 13.3 1 
Ann Arbor, Mich 14 6 42.9 7 50.0 1 7.1 0 
Atlanta, Ga 403 303 75.2 71 17.6 29 7.2 8 
Austin, Tex 81 52 64.2 20 24.7 9 11.1 1 
Bakersfield, Calif 49 41 83.7 5 10.2 3 6.1 0 
Baltimore, Md 119 88 73.9 14 11.8 17 14.3 5 
Baton Rouge, La 22 18 81.8 3 13.6 1 4.5 0 
Bergen-Passaic, NJ 78 56 71.8 16 20.5 6 7.7 1 
Birmingham, Ala 80 67 83.8 10 12.5 3 3.8 0 
Boston, Mass 276 172 62.3 87 31.5 17 6.2 5 
Buffalo, NY 20 14 70.0 6 30.0 0 0.0 0 
Charleston, SC 38 19 50.0 15 39.5 4 10.5 3 
Charlotte, NC 104 79 76.0 21 20.2 4 3.8 1 
Chicago, Ill 657 465 70.8 150 22.8 42 6.4 11 
Cincinnati, Ohio 44 36 81.8 8 18.2 0 0.0 0 
Cleveland, Ohio 108 63 58.3 37 34.3 8 7.4 5 
Colorado Springs, Colo 7 5 71.4 2 28.6 0 0.0 0 
Columbia, SC 27 12 44.4 13 48.1 2 7.4 1 
Columbus, Ohio 85 58 68.2 25 29.4 2 2.4 0 
Dallas, Tex 229 171 74.7 34 14.8 24 10.5 4 
Dayton, Ohio 16 11 68.8 4 25.0 1 6.3 0 
Denver, Colo 63 37 58.7 17 27.0 9 14.3 1 
Detroit, Mich 194 132 68.0 53 27.3 9 4.6 1 
El Paso, Tex 56 38 67.9 13 23.2 5 8.9 2 
Fort Lauderdale, Fla 102 74 72.5 24 23.5 4 3.9 1 
Fort Wayne, Ind 12 10 83.3 2 16.7 0 0.0 0 
Fort Worth, Tex 101 72 71.3 17 16.8 12 11.9 1 
Fresno, Calif 105 82 78.1 15 14.3 8 7.6 3 
Gary, Ind 24 22 91.7 1 4.2 1 4.2 1 
Grand Rapids, Mich 33 21 63.6 8 24.2 4 12.1 1 
Greensboro, NC 41 28 68.3 9 22.0 4 9.8 0 
Greenville, SC 42 28 66.7 12 28.6 2 4.8 1 
Harrisburg, Pa 21 13 61.9 8 38.1 0 0.0 0 
Hartford, Conn 29 18 62.1 9 31.0 2 6.9 1 
Honolulu, Hawaii 108 89 82.4 15 13.9 4 3.7 0 
Houston, Tex 432 313 72.5 89 20.6 30 6.9 7 
Indianapolis, Ind 48 37 77.1 6 12.5 5 10.4 3 
Jacksonville, Fla 125 96 76.8 24 19.2 5 4.0 3 
Jersey City, NJ 85 56 65.9 19 22.4 10 11.8 1 
Kansas City, Mo 73 46 63.0 19 26.0 6 8.2 1 
Knoxville, Tenn 28 23 82.1 2 7.1 3 10.7 0 
Las Vegas, Nev 88 73 83.0 10 11.4 5 5.7 2 
Little Rock, Ark 21 15 71.4 2 9.5 4 19.0 0 
Los Angeles, Calif 1,140 839 73.6 199 17.5 102 8.9 21 
Louisville, Ky 36 27 75.0 8 22.2 0 0.0 0 
McAllen, Tex 80 64 80.0 12 15.0 4 5.0 0 
Memphis, Tenn 92 63 68.5 23 25.0 6 6.5 3 
Miami, Fla 280 221 78.9 42 15.0 17 6.1 6 
Middlesex, NJ 84 45 53.6 32 38.1 7 8.3 2 
Milwaukee, Wis 46 31 67.4 13 28.3 2 4.3 0 
Minneapolis-St. Paul, Minn 137 66 48.2 61 44.5 10 7.3 2 
Mobile, Ala 31 27 87.1 2 6.5 2 6.5 0 
1. Includes cases with pulmonary listed as major site of disease and no additional site of disease.

2. Includes cases with pleural, lymphatic, bone and/or joint, meningeal, peritoneal, or other site, excluding pulmonary, listed as 

major site of disease.

3. Includes miliary cases. 

Note: 6 (<0.1%) cases had missing and/or unknown site of disease.
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Table 38. (Cont'd) Tuberculosis Cases by Form of Disease: Metropolitan Statistical Areas
with >500,000 Population, 2000
 Cases with Both Pulmonary
 and Extrapulmonary Disease
Metropolitan    Total   Pulmonary1       Extrapulmonary2 Total3 Miliary
Statistical Area   Cases No. % No. % No. % No.
Monmouth-Ocean City, NJ 41 26 63.4 13 31.7 2 4.9 1
Nashville, Tenn 96 75 78.1 11 11.5 10 10.4 1
Nassau-Suffolk, NY 137 90 65.7 35 25.5 12 8.8 0
New Haven, Conn 54 36 66.7 16 29.6 2 3.7 0
New Orleans, La 142 120 84.5 20 14.1 2 1.4 0
New York, NY 1,427 983 68.9 295 20.7 148 10.4 36
Newark, NJ 194 133 68.6 37 19.1 24 12.4 8
Norfolk, Va 57 37 64.9 13 22.8 7 12.3 4
Oakland, Calif 309 222 71.8 67 21.7 20 6.5 6
Oklahoma City, Okla 64 49 76.6 6 9.4 9 14.1 2
Omaha, Neb 12 6 50.0 5 41.7 1 8.3 0
Orange County, Calif 246 175 71.1 45 18.3 25 10.2 3
Orlando, Fla 140 118 84.3 7 5.0 15 10.7 2
Philadelphia, Pa 263 175 66.5 71 27.0 17 6.5 5
Phoenix, Ariz 172 142 82.6 12 7.0 18 10.5 4
Pittsburgh, Pa 38 28 73.7 10 26.3 0 0.0 0
Portland, Ore 83 56 67.5 22 26.5 5 6.0 1
Providence, RI 49 27 55.1 13 26.5 9 18.4 1
Raleigh-Durham, NC 84 65 77.4 14 16.7 5 6.0 1
Richmond, Va 16 14 87.5 1 6.3 1 6.3 0
Riverside-San Bernardino, Calif 175 122 69.7 40 22.9 13 7.4 5
Rochester, NY 40 27 67.5 10 25.0 3 7.5 0
Sacramento, Calif 126 107 84.9 14 11.1 5 4.0 1
St. Louis, Mo 107 82 76.6 18 16.8 7 6.5 2
Salt Lake City, Utah 41 25 61.0 11 26.8 5 12.2 1
San Antonio, Tex 99 79 79.8 13 13.1 7 7.1 2
San Diego, Calif 296 215 72.6 58 19.6 23 7.8 3
San Francisco, Calif 227 164 72.2 38 16.7 25 11.0 4
San Jose, Calif 235 154 65.5 72 30.6 8 3.4 2
Sarasota, Fla 25 19 76.0 6 24.0 0 0.0 0 
Scranton, Pa 15 12 80.0 2 13.3 1 6.7 0
Seattle, Wash 148 98 66.2 38 25.7 12 8.1 2
Springfield, Mass 16 10 62.5 6 37.5 0 0.0 0
Stockton, Calif 72 51 70.8 15 20.8 6 8.3 5
Syracuse, NY 26 15 57.7 8 30.8 3 11.5 0
Tacoma, Wash 34 22 64.7 11 32.4 1 2.9 0
Tampa-St. Petersburg, Fla 127 113 89.0 10 7.9 4 3.1 0
Toledo, Ohio 9 8 88.9 1 11.1 0 0.0 0
Tucson, Ariz 23 15 65.2 6 26.1 2 8.7 0
Tulsa, Okla 24 16 66.7 3 12.5 5 20.8 1
Vallejo, Calif 30 24 80.0 4 13.3 2 6.7 0
Ventura, Calif 44 25 56.8 8 18.2 11 25.0 1
Washington, DC 385 260 67.5 87 22.6 38 9.9 12
West Palm Beach, Fla 76 55 72.4 15 19.7 6 7.9 0
Wichita, Kan 29 19 65.5 6 20.7 4 13.8 0 
Wilmington, Del 17 12 70.6 5 29.4 0 0.0 0
Youngstown, Ohio 17 13 76.5 4 23.5 0 0.0 0
Total - 102 Areas 12,367 8,821 71.3 2,557 20.7 983 7.9 226 
San Juan, Puerto Rico 68 57 83.8 10 14.7 1 1.5 0
1. Includes cases with pulmonary listed as major site of disease and no additional site of disease.
2. Includes cases with pleural, lymphatic, bone and/or joint, meningeal, peritoneal, or other site, excluding pulmonary, listed as major site of 
disease.  
3. Includes miliary cases. 
Note: 6 (<0.1%) cases had missing and/or unknown site of disease.
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Table 39. Tuberculosis Cases by Age Group: Metropolitan Statistical Areas with 
>500,000 Population, 2000
Metropolitan  Total Unknown or
Statistical Area Cases Under 5 5 - 14 15 - 24 25 - 44   45 - 64   65+ Missing
Akron, Ohio 16 0 0 1 4 1 10 0
Albany-Schenectady, NY 29 0 0 2 6 5 16 0
Albuquerque, NM 6 0 0 0 2 4 0 0
Allentown, Pa 15 0 1 3 3 4 4 0
Ann Arbor, Mich 14 1 0 3 7 3 0 0
Atlanta, Ga 403 25 16 56 146 120 39 1
Austin, Tex 81 4 2 9 38 23 5 0
Bakersfield, Calif 49 5 1 5 12 18 8 0
Baltimore, Md 119 3 2 13 42 28 31 0
Baton Rouge, La 22 0 0 1 7 8 6 0
Bergen-Passaic, NJ 78 2 1 4 35 24 12 0
Birmingham, Ala 80 5 2 3 30 23 17 0
Boston, Mass 276 5 7 35 107 68 54 0
Buffalo, NY 20 1 1 4 4 3 7 0
Charleston, SC 38 1 2 1 14 10 10 0
Charlotte, NC 104 7 1 14 47 19 16 0
Chicago, Ill 657 17 15 69 226 197 133 0
Cincinnati, Ohio 44 1 0 1 12 19 11 0
Cleveland, Ohio 108 1 1 9 26 34 37 0
Colorado Springs, Colo 7 1 0 0 1 1 4 0
Columbia, SC 27 0 1 2 12 5 7 0
Columbus, Ohio 85 2 4 26 32 17 4 0
Dallas, Tex 229 6 5 27 102 59 30 0
Dayton, Ohio 16 1 0 1 3 6 5 0
Denver, Colo 63 2 0 8 22 19 12 0
Detroit, Mich 194 11 3 16 58 66 40 0
El Paso, Tex 56 4 2 5 10 16 19 0
Fort Lauderdale, Fla 102 4 4 3 51 26 14 0
Fort Wayne, Ind 12 1 0 2 3 2 4 0
Fort Worth, Tex 101 5 9 9 34 31 13 0
Fresno, Calif 105 7 9 3 26 41 19 0
Gary, Ind 24 0 1 1 6 7 9 0
Grand Rapids, Mich 33 2 1 5 16 3 6 0
Greensboro, NC 41 2 0 4 15 10 10 0
Greenville, SC 42 0 1 4 13 17 7 0
Harrisburg, Pa 21 0 1 0 10 5 5 0
Hartford, Conn 29 1 1 4 11 8 4 0
Honolulu, Hawaii 108 1 0 9 27 38 33 0
Houston, Tex 432 15 11 39 163 146 58 0
Indianapolis, Ind 48 8 3 3 12 10 12 0
Jacksonville, Fla 125 3 0 4 47 58 13 0
Jersey City, NJ 85 2 5 18 32 18 10 0
Kansas City, Mo 73 1 2 7 33 18 12 0
Knoxville, Tenn 28 0 0 0 4 11 13 0
Las Vegas, Nev 88 1 6 5 34 29 13 0
Little Rock, Ark 21 0 0 3 5 6 7 0
Los Angeles, Calif 1,140 42 30 133 354 345 236 0
Louisville, Ky 36 0 0 0 10 14 12 0
McAllen, Tex 80 6 2 7 23 22 20 0
Memphis, Tenn 92 4 1 14 43 18 12 0
Miami, Fla 280 4 3 18 117 95 43 0
Middlesex, NJ 84 2 1 12 39 15 15 0
Milwaukee, Wis 46 0 1 5 20 8 12 0
Minneapolis-St. Paul, Minn 137 4 3 37 56 28 9 0
Mobile, Ala 31 1 0 4 9 8 9 0
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Table 39. (Cont'd) Tuberculosis Cases by Age Group: Metropolitan Statistical Areas with 
>500,000 Population, 2000
Metropolitan   Total     Unknown or
Statistical Area Cases Under 5 5 - 14   15 - 24   25 - 44   45 - 64   65+ Missing
Monmouth-Ocean City, NJ 41 0 0 4 12 9 16 0
Nashville, Tenn 96 4 2 5 37 27 21 0
Nassau-Suffolk, NY 137 1 4 16 49 42 25 0
New Haven, Conn 54 2 2 4 21 9 16 0
New Orleans, La 142 11 8 9 35 52 27 0
New York, NY 1,427 34 46 144 596 373 234 0
Newark, NJ 194 5 4 26 61 55 43 0
Norfolk, Va 57 2 0 6 17 20 12 0
Oakland, Calif 309 7 5 28 102 82 85 0
Oklahoma City, Okla 64 1 0 7 27 17 12 0
Omaha, Neb 12 2 1 0 8 0 1 0
Orange County, Calif 246 10 4 25 95 60 52 0
Orlando, Fla 140 4 0 13 49 50 24 0
Philadelphia, Pa 263 11 9 25 92 71 54 1
Phoenix, Ariz 172 8 3 25 74 38 24 0
Pittsburgh, Pa 38 0 1 4 10 7 16 0
Portland, Ore 83 5 2 8 40 15 13 0
Providence, RI 49 3 2 4 17 12 11 0
Raleigh-Durham, NC 84 1 1 11 34 24 13 0
Richmond, Va 16 0 1 0 7 4 4 0
Riverside-San Bernardino, Calif 175 5 5 13 57 49 46 0
Rochester, NY 40 3 3 2 13 7 12 0
Sacramento, Calif 126 3 3 9 33 49 29 0
St. Louis, Mo 107 3 5 4 36 29 30 0
Salt Lake City, Utah 41 0 0 5 14 16 6 0
San Antonio, Tex 99 3 0 11 29 36 20 0
San Diego, Calif 296 14 14 36 107 69 56 0
San Francisco, Calif 227 4 5 13 64 65 76 0
San Jose, Calif 235 4 5 26 104 60 36 0
Sarasota, Fla 25 0 1 4 7 5 8 0
Scranton, Pa 15 3 0 1 6 1 4 0
Seattle, Wash 148 2 1 18 62 39 26 0
Springfield, Mass 16 0 0 1 9 3 3 0
Stockton, Calif 72 3 1 5 16 26 21 0
Syracuse, NY 26 0 1 0 9 10 6 0
Tacoma, Wash 34 1 2 2 11 9 9 0
Tampa-St. Petersburg, Fla 127 3 4 9 42 41 28 0
Toledo, Ohio 9 1 0 0 7 0 1 0
Tucson, Ariz 23 0 1 2 6 6 8 0
Tulsa, Okla 24 1 0 0 10 7 6 0
Vallejo, Calif 30 2 0 2 6 11 9 0
Ventura, Calif 44 1 1 3 19 10 10 0
Washington, DC 385 7 7 56 147 116 52 0
West Palm Beach, Fla 76 1 2 10 31 20 12 0
Wichita, Kan 29 1 0 5 13 7 3 0
Wilmington, Del 17 1 1 3 5 5 2 0
Youngstown, Ohio 17 1 0 1 2 5 8 0
Total - 102 Areas 12,367 399 319 1,276 4,469 3,505 2,397 2
San Juan, Puerto Rico 68 1 1 3 19 29 15 0
 53 
Table 40. Tuberculosis Cases by Race/Ethnicity: Metropolitan Statistical Areas with >500,000 Population, 2000
 American Indian Asian Unknown
Metropolitan  Total        White,        Black, or or or
Statistical Area  Cases non-Hispanic non-Hispanic Hispanic1 Alaskan Native Pacific Islander Missing
Akron, Ohio 16 9 5 1 0 1 0
Albany-Schenectady, NY 29 14 6 0 0 9 0
Albuquerque, NM 6 1 1 2 1 0 1
Allentown, Pa 15 7 1 5 0 2 0
Ann Arbor, Mich 14 3 7 0 0 4 0
Atlanta, Ga 403 47 254 44 0 53 5
Austin, Tex 81 14 17 37 0 13 0
Bakersfield, Calif 49 6 4 22 2 15 0
Baltimore, Md 119 29 66 9 0 15 0
Baton Rouge, La 22 11 4 0 0 6 1
Bergen-Passaic, NJ 78 16 18 25 1 18 0
Birmingham, Ala 80 23 51 3 0 3 0
Boston, Mass 276 73 74 39 1 89 0
Buffalo, NY 20 8 8 1 0 3 0
Charleston, SC 38 4 28 2 0 4 0
Charlotte, NC 104 23 54 19 0 8 0
Chicago, Ill 657 107 273 139 7 127 4
Cincinnati, Ohio 44 22 20 0 0 2 0
Cleveland, Ohio 108 32 61 4 0 11 0
Colorado Springs, Colo 7 3 0 1 0 3 0
Columbia, SC 27 5 18 0 0 4 0
Columbus, Ohio 85 21 50 9 0 5 0
Dallas, Tex 229 36 81 78 2 31 1
Dayton, Ohio 16 9 7 0 0 0 0
Denver, Colo 63 13 12 23 3 12 0
Detroit, Mich 194 53 115 4 1 21 0
El Paso, Tex 56 2 1 53 0 0 0
Fort Lauderdale, Fla 102 19 58 18 0 7 0
Fort Wayne, Ind 12 7 3 1 0 1 0
Fort Worth, Tex 101 25 27 32 1 15 1
Fresno, Calif 105 16 8 54 4 23 0
Gary, Ind 24 9 7 7 0 1 0
Grand Rapids, Mich 33 11 7 10 0 5 0
Greensboro, NC 41 11 16 7 0 7 0
Greenville, SC 42 18 19 1 0 4 0
Harrisburg, Pa 21 12 1 1 0 6 1
Hartford, Conn 29 6 9 7 0 7 0
Honolulu, Hawaii 108 0 0 0 0 107 1
Houston, Tex 432 72 151 145 0 64 0
Indianapolis, Ind 48 14 23 6 0 5 0
Jacksonville, Fla 125 35 74 3 0 13 0
Jersey City, NJ 85 8 15 29 0 33 0
Kansas City, Mo 73 17 34 10 0 11 1
Knoxville, Tenn 28 23 3 2 0 0 0
Las Vegas, Nev 88 24 15 24 4 21 0
Little Rock, Ark 21 13 4 1 0 3 0
Los Angeles, Calif 1,140 110 145 513 0 372 0
Louisville, Ky 36 20 12 1 0 3 0
McAllen, Tex 80 1 0 78 0 0 1
Memphis, Tenn 92 15 69 2 0 5 1
Miami, Fla 280 32 153 88 0 7 0
Middlesex, NJ 84 13 7 17 0 47 0
Milwaukee, Wis 46 9 22 3 0 12 0
Minneapolis-St. Paul, Minn 137 11 79 18 2 26 1
Mobile, Ala 31 9 20 0 0 2 0
1. Persons of Hispanic origin may be of any race.
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Table 40. (Cont'd) Tuberculosis Cases by Race/Ethnicity: Metropolitan Statistical Areas with 
>500,000 Population, 2000 
  American Indian Asian Unknown
Metropolitan  Total        White,        Black, or or or
Statistical Area Cases  non-Hispanic  non-Hispanic  Hispanic1 Alaskan Native Pacific Islander Missing
Monmouth-Ocean City, NJ 41 17 3 7 0 14 0
Nashville, Tenn 96 39 44 5 1 3 4
Nassau-Suffolk, NY 137 33 33 47 0 23 1
New Haven, Conn 54 26 16 6 0 5 1
New Orleans, La 142 40 81 7 0 13 1
New York, NY 1,427 148 513 394 1 369 2
Newark, NJ 194 29 97 40 0 28 0
Norfolk, Va 57 11 23 3 0 20 0
Oakland, Calif 309 31 72 43 1 162 0
Oklahoma City, Okla 64 28 13 7 3 13 0
Omaha, Neb 12 0 8 3 0 1 0
Orange County, Calif 246 21 5 85 0 135 0
Orlando, Fla 140 37 75 18 0 10 0
Philadelphia, Pa 263 40 120 20 1 76 6
Phoenix, Ariz 172 26 13 98 10 22 3
Pittsburgh, Pa 38 22 11 0 0 5 0
Portland, Ore 83 27 12 18 0 26 0
Providence, RI 49 16 11 10 1 11 0
Raleigh-Durham, NC 84 15 51 13 0 5 0
Richmond, Va 16 3 6 0 0 7 0
Riverside-San Bernardino, Calif 175 35 15 91 0 34 0
Rochester, NY 40 12 17 5 1 5 0
Sacramento, Calif 126 29 13 10 0 72 2
St. Louis, Mo 107 34 54 5 0 14 0
Salt Lake City, Utah 41 19 4 12 0 6 0
San Antonio, Tex 99 20 5 64 0 10 0
San Diego, Calif 296 28 24 142 0 102 0
San Francisco, Calif 227 24 11 36 2 154 0
San Jose, Calif 235 9 3 36 0 187 0
Sarasota, Fla 25 13 6 6 0 0 0
Scranton, Pa 15 9 0 5 0 1 0
Seattle, Wash 148 29 36 14 3 66 0
Springfield, Mass 16 11 0 3 0 2 0
Stockton, Calif 72 9 6 22 0 35 0
Syracuse, NY 26 10 8 1 0 6 1
Tacoma, Wash 34 8 5 4 0 17 0
Tampa-St. Petersburg, Fla 127 47 58 10 0 12 0
Toledo, Ohio 9 3 4 1 0 1 0
Tucson, Ariz 23 3 2 12 3 3 0
Tulsa, Okla 24 10 7 0 5 2 0
Vallejo, Calif 30 5 2 6 0 17 0
Ventura, Calif 44 6 0 29 1 8 0
Washington, DC 385 46 163 67 1 108 0
West Palm Beach, Fla 76 17 34 21 0 4 0
Wichita, Kan 29 9 4 5 0 11 0
Wilmington, Del 17 1 7 1 0 8 0
Youngstown, Ohio 17 9 7 0 0 0 1
Total - 102 Areas 12,367 2,215 3,919 3,030 63 3,099 41 
San Juan, Puerto Rico 68 0 0 68 0 0 0
1. Persons of Hispanic origin may be of any race.
 55 
Table 41. Tuberculosis Cases, U.S.-born Persons and Foreign-born Persons: Metropolitan 
Statistical Areas with >500,000 Population, 2000 
Metropolitan   Total  U.S.-born Persons   Foreign-born Persons1  Unknown
Statistical Area Cases No. % No. % No. %
Akron, Ohio 16 12 75.0 4 25.0 0 0.0
Albany-Schenectady, NY 29 16 55.2 13 44.8 0 0.0
Albuquerque, NM 6 5 83.3 1 16.7 0 0.0
Allentown, Pa 15 11 73.3 4 26.7 0 0.0
Ann Arbor, Mich 14 0 0.0 14 100.0 0 0.0
Atlanta, Ga 403 283 70.2 117 29.0 3 0.7
Austin, Tex 81 50 61.7 31 38.3 0 0.0
Bakersfield, Calif 49 22 44.9 27 55.1 0 0.0
Baltimore, Md 119 92 77.3 27 22.7 0 0.0
Baton Rouge, La 22 16 72.7 6 27.3 0 0.0 
Bergen-Passaic, NJ 78 28 35.9 50 64.1 0 0.0
Birmingham, Ala 80 73 91.3 7 8.8 0 0.0
Boston, Mass 276 69 25.0 207 75.0 0 0.0
Buffalo, NY 20 15 75.0 5 25.0 0 0.0
Charleston, SC 38 33 86.8 5 13.2 0 0.0
Charlotte, NC 104 71 68.3 33 31.7 0 0.0
Chicago, Ill 657 418 63.6 238 36.2 1 0.2
Cincinnati, Ohio 44 37 84.1 7 15.9 0 0.0
Cleveland, Ohio 108 85 78.7 23 21.3 0 0.0
Colorado Springs, Colo 7 2 28.6 5 71.4 0 0.0
Columbia, SC 27 22 81.5 5 18.5 0 0.0
Columbus, Ohio 85 31 36.5 54 63.5 0 0.0
Dallas, Tex 229 127 55.5 102 44.5 0 0.0
Dayton, Ohio 16 16 100.0 0 0.0 0 0.0
Denver, Colo 63 24 38.1 39 61.9 0 0.0
Detroit, Mich 194 154 79.4 40 20.6 0 0.0
El Paso, Tex 56 23 41.1 33 58.9 0 0.0
Fort Lauderdale, Fla 102 40 39.2 62 60.8 0 0.0
Fort Wayne, Ind 12 9 75.0 3 25.0 0 0.0
Fort Worth, Tex 101 52 51.5 49 48.5 0 0.0
Fresno, Calif 105 41 39.0 64 61.0 0 0.0
Gary, Ind 24 20 83.3 3 12.5 1 4.2
Grand Rapids, Mich 33 9 27.3 24 72.7 0 0.0
Greensboro, NC 41 24 58.5 17 41.5 0 0.0
Greenville, SC 42 36 85.7 6 14.3 0 0.0
Harrisburg, Pa 21 10 47.6 11 52.4 0 0.0
Hartford, Conn 29 13 44.8 16 55.2 0 0.0
Honolulu, Hawaii 108 22 20.4 84 77.8 2 1.9
Houston, Tex 432 264 61.1 168 38.9 0 0.0
Indianapolis, Ind 48 34 70.8 13 27.1 1 2.1
Jacksonville, Fla 125 105 84.0 20 16.0 0 0.0
Jersey City, NJ 85 14 16.5 70 82.4 1 1.2
Kansas City, Mo 73 46 63.0 25 34.2 2 2.7
Knoxville, Tenn 28 26 92.9 2 7.1 0 0.0
Las Vegas, Nev 88 42 47.7 45 51.1 1 1.1
Little Rock, Ark 21 17 81.0 3 14.3 1 4.8
Los Angeles, Calif 1,140 304 26.7 832 73.0 4 0.4
Louisville, Ky 36 32 88.9 4 11.1 0 0.0
McAllen, Tex 80 36 45.0 43 53.8 1 1.2
Memphis, Tenn 92 83 90.2 9 9.8 0 0.0
Miami, Fla 280 102 36.4 177 63.2 1 0.4
Middlesex, NJ 84 15 17.9 69 82.1 0 0.0
Milwaukee, Wis 46 24 52.2 22 47.8 0 0.0
Minneapolis-St. Paul, Minn 137 22 16.1 115 83.9 0 0.0
Mobile, Ala 31 29 93.5 2 6.5 0 0.0
1. Includes persons born outside the United States, American Samoa, the Federated States of Micronesia, Guam, the Republic of the Marshall Islands, 
Midway Island, the Commonwealth of the Northern Mariana Islands, Puerto Rico, the Republic of Palau, U.S. Minor Outlying Islands, U.S. Miscellaneous 
Pacific Islands, and the U.S. Virgin Islands.       
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  Appendix A 
 
 
Technical Notes 
        
National Surveillance for Tuberculosis 
      All reporting areas (i.e., the 50 states, the District of Columbia, New York City, Puerto Rico, 
and other U.S. jurisdictions in the Pacific and Caribbean) report tuberculosis (TB) cases to CDC 
using a standard case report form, Report of a Verified Case of Tuberculosis (RVCT).1   Reported 
TB cases are verified according to the TB case definition for public health surveillance (MMWR 
1997;46[No. RR-10]:40-1).  Cases may be verified using the laboratory or clinical case 
definition.  A case may be verified by the laboratory case definition either by (1) isolation of M. 
tuberculosis from a clinical specimen, OR (2) demonstration of acid-fast bacilli (AFB) in a 
clinical specimen when a culture has not been or cannot be obtained.  A case may be verified by 
the clinical case definition in the presence of ALL of the following clinical criteria: (a) a positive 
tuberculin skin test result, (b) other signs and symptoms compatible with TB, such as an 
abnormal, unstable (worsening or improving) chest radiograph, or clinical evidence of current 
disease, (c) treatment with two or more antituberculosis medications, and (d) a completed 
diagnostic evaluation.  When patients are diagnosed with TB but do not meet the case definition 
(e.g., anergic patients with a clinical picture consistent with TB but without laboratory evidence 
of M. tuberculosis), reporting areas also have the option of verifying TB cases based on provider 
diagnosis.  
      In January 1993, in conjunction with state and local health departments, CDC implemented 
an expanded surveillance system for TB to collect additional data to better monitor and target 
groups at risk for TB disease, to estimate and follow the extent of drug-resistant TB, and to 
evaluate outcomes of TB cases.  The RVCT form for reporting TB cases was revised to collect 
information on occupation, the initial drug regimen, human immunodeficiency virus (HIV) test 
results, history of substance abuse and homelessness, and residence in correctional or long-term 
care facilities at the time of diagnosis.  RVCT Follow Up Report-1 was added to collect drug 
susceptibility results for the initial M. tuberculosis isolate from patients with culture-positive 
disease.  To evaluate the outcomes of TB therapy, RVCT Follow Up Report-2 was added to 
collect information on the reason and date therapy was stopped, the type of health care provider, 
sputum culture conversion, the use of directly observed therapy, and the results of drug 
susceptibility testing for the final M. tuberculosis isolate from patients with culture-positive 
disease.  Since 1993, RVCT data have been reported to CDC using software specifically 
developed for expanded TB surveillance (i.e., SURVS-TB, 1993-1997; TIMS, 1998-2000).  The 
instructions for completing the RVCT forms and the definitions for all data items were included 
in the software user’s guide.  The summary data presented in this publication for 2000 (and for  
1998, Tables 33-35) and the trend data for 1993-2000 (Tables 7-10) were received at CDC via 
TIMS by April 17, 2001. 
 
__________________________________________________ 
 
 
1Other U.S. jurisdictions include American Samoa, the Commonwealth of the Northern Mariana Islands, the Federated States of Micronesia, 
Guam, the Republic of the Marshall Islands, the Republic of Palau, and the U.S. Virgin Islands.  RVCT data for 2000 were available from the 
Commonweatlth of the Northern Mariana Islands and Guam. 
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Completion of Tuberculosis Therapy       
      Tables 9 and 35 are recent additions to this publication and present rates of completion of TB 
therapy (COT).  Data collected by RVCT Follow Up Report-2 on date and reason therapy 
stopped (e.g., patient completed therapy, moved, was lost) were used to calculate rates of COT.  
Cases were stratified by the indicated length of therapy, based on current American Thoracic 
Society/CDC treatment guidelines2 and the patient’s initial drug susceptibility test results, age, 
and site of disease.  The adequacy of the treatment regimen (e.g., the sufficiency of the duration 
of therapy, the appropriateness of the prescribed TB drugs) was not evaluated in this analysis.  
Acquired drug resistance during therapy with the need for a longer duration of therapy was also 
not considered in this analysis. 
      In Table 35, the first column shows the total number of cases reported during 1998.  The 
remaining columns are grouped under three headings: therapy of 1 year or less indicated, therapy 
greater than 1 year indicated, and overall.  For patients with an initial isolate resistant to rifampin 
and for pediatric patients (age under 15 years old) with meningeal, bone or joint, or miliary 
disease, data were included under the category of greater than 1 year of therapy indicated.  For 
all other patients, including those with culture-negative disease, those with an unknown culture 
status, and those with culture-positive disease but unknown initial drug susceptibility test results, 
data were included under the category of 1 year or less of therapy indicated.  Table 9 presents 
data only for the category of therapy of 1 year or less indicated.     
      In Table 35, each group under an indicated length of therapy has an initial column showing 
the number of cases in persons who were alive at diagnosis and prescribed an initial regimen of 
one or more drugs, and who did not die during therapy.  This number was used as the 
denominator in COT rate calculations.  COT rates, shown as percentages, were only calculated 
for areas reporting reason therapy stopped for at least 90% of cases shown in the overall column. 
 For the group with an indicated length of therapy of 1 year or less, rates are shown for both 
completion of therapy in 1 year or less (COT <1 year) and for COT, regardless of duration of 
therapy (i.e., duration of therapy <1 year, >1 year, or unknown).  For COT <1 year, the 
numerator included only those patients completing therapy in <365 days (based on the dates 
therapy started and stopped).  Patients with missing dates were classified as “treatment not 
completed” for this calculation.  Rates of COT, regardless of duration of therapy, were 
calculated by dividing the number of patients reported as having completed therapy by the 
number of patients listed in the first column of each group.  Patients with an outcome other than 
completed therapy (i.e., moved, lost, refused treatment, and other) were classified as “treatment 
not completed.”  Patients with an unknown outcome were also classified as “treatment not 
completed.”  For the remaining two groups of indicated therapy length (greater than 1 year and 
overall), only rates of COT, regardless of duration of therapy, are presented.  Table 9 provides 
rates for COT <1 year and for COT, regardless of duration of therapy, only for the group with an 
indicated therapy of 1 year or less. 
 
Acknowledgment: Tables 9 and 35 were developed in collaboration with the Field Services 
Branch, Division of Tuberculosis Elimination, CDC.  
  
 
                                                                                                              
                                                                       
2ATS/CDC. Treatment of tuberculosis and tuberculosis infection in adults and children. Am J Respir Crit Care Med 1994;149:1359-74. 
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Site of TB Disease   
      Tables 5, 6, 21, 22, and 38 reflect a recent change in the definition of miliary disease that is 
used in this publication.  Miliary disease is now classified as both an extrapulmonary and a 
pulmonary form of TB.  In publications prior to 1997, miliary disease was classified as 
extrapulmonary TB unless pulmonary disease was reported as the major site of TB disease.    
  
Reporting of HIV Infection  
      Table 31 shows information on HIV status for TB cases among persons aged 25-44 years, the 
age group in which 75% of AIDS cases occur (CDC. HIV/AIDS Surveillance Report 1999;11[No. 
2]:16).  The information on HIV status for TB cases reported in 2000 is incomplete.  Reasons for 
incomplete reporting of HIV test results to the national surveillance system include concerns about 
confidentiality, which may limit the exchange of data between TB and HIV/AIDS programs; laws 
and regulations in certain states and local jurisdictions that have been interpreted as prohibiting the 
HIV/AIDS program from sharing the HIV status of TB patients with the TB program, or from 
reporting patients with TB and AIDS to the TB program; and reluctance by health care providers to 
report HIV test results to the TB surveillance program staff.  In addition, health care providers may 
not offer counseling and HIV testing to some TB patients because of a lack of resources or of 
appropriately trained staff, or due to the perception that selected patients (e.g., foreign-born 
persons) are not at risk for HIV infection. 
      Data on the HIV infection status of reported TB cases in 2000 should be interpreted with 
caution.  These data are not representative of all TB patients with HIV infection.  HIV testing is 
performed after a patient receives counseling and gives informed consent.  Since testing is 
voluntary, some TB patients may decline HIV testing.  TB patients who are tested anonymously 
may choose not to share the results of HIV testing with their health care provider.  TB patients 
managed in the private sector may receive confidential HIV testing, but results may not be reported 
to the TB program in the health department.  In addition, many factors may influence HIV testing 
of TB patients, including the extent to which testing is targeted or routinely offered to specific 
groups (e.g., 25- to 44- year-old males, injecting drug users, homeless persons), and the availability 
of and access to HIV testing services.  These data do not provide a minimum estimate of the 
proportion of TB patients known to be HIV infected in a reporting area. 
  
Tabulation and Presentation of TB Data   
      This report primarily presents summary data for TB cases reported to CDC in 2000.  Data from 
the RVCT Follow Up Report-2 (i.e., completion of therapy, use of directly observed therapy, and  
type of health care provider) are presented for cases reported in 1998.  In addition, trend data are 
presented in Tables 1 through 10.  TB cases are tabulated by the year in which the reporting area 
verified that the patient had TB and included the patient in its official annual TB case count.  Totals 
for the U.S. only include data from the 50 states, the District of Columbia, and New York City.  
Age group tabulations are based on the patient’s age in the month and year the patient was reported 
to the health department as a suspected TB case.  State or metropolitan area data tabulations are 
based on the patient’s residence at diagnosis of TB (see Appendix C: “Recommendations for 
Counting Reported Tuberculosis Cases”). 
      Tables 37 through 41 present data by metropolitan statistical areas (MSAs) with a 2000 Census 
population of 500,000 or more.  Metropolitan areas are defined by the federal Office of 
Management and Budget, and the definitions effective as of June 30, 1999, were used for this 
publication (www.census.gov/population/www/estimates/metrodef.html).  The metropolitan area 
definitions apply to all areas except the six New England states; for these states, the New England   
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County Metropolitan Areas (NECMAs) are used.  Metropolitan areas are named for a central city in 
the MSA or NECMA, may include several cities and counties, and may cross state boundaries.  For 
example, the TB cases and case rates presented for the District of Columbia in Table 15 include 
only persons residing within the geographic boundaries of the District.  However, the TB cases and 
case rates for Washington, D.C. (Table 37), include persons residing within the several counties in 
the metropolitan area, including counties in Maryland, Virginia, and West Virginia.  A list of the 
cities and counties that comprised each metropolitan area in 2000 is available in U.S. Census Table 
1 located at www.census.gov/population/www/cen2000/phc-t3.html.  
  
Rates 
      Rates are expressed as the number of cases reported each calendar year per 100,000 population.  
Population denominators used in calculating TB rates were based on official census and midyear (July 
1) post-census estimates from the U.S. Census Bureau.  Specifically, in Tables 1 and 15, the U.S. total 
and state populations for 2000 were obtained from the U.S. Census Bureau Table 2 located at  
www.census.gov/population/www/cen2000/respop.html.   In Tables 2 and 3, populations by age, race, 
and Hispanic origin were obtained from Table DP-1 found in the U.S. Census publication, Profiles of 
General Demographic Characteristics, 2000 (www.census.gov/prod/cen2000/index.html).  In Table 
12, populations by age, sex, race, and Hispanic origin were extrapolated to the April 2000 population 
based on July 1, 2000, population estimates.  In Table 4, the populations for U.S.-born and foreign-born 
for 1990-1999 were obtained from Quarterly Estimates of the United States Foreign-born and Native 
Resident Populations: April 1, 1990, to July 1, 1999  (www.census.gov/population/estimates/nation/ 
nativity/ fbtab001.txt) and 2000 population estimates reported in the U.S. Census Bureau Current 
Population Reports, P20-534, The Foreign-born Population in the United States: March 2000 were 
extrapolated to the April 2000 population. 
 
Mortality Data 
      Official TB mortality statistics for the United States are compiled by the National Center for Health 
Statistics (NCHS), CDC.  The annual mortality rate is calculated as the number of deaths due to TB in 
that year, divided by the estimated population for the year, multiplied by 100,000 (Table 1).  The 
number of deaths for 1999 was obtained from the NCHS National Vital Statistics Reports, Vol. 49, No. 
3, June 26, 2001.   The number of deaths for 2000 was not available at the time of this publication. 
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 Appendix B 
 
Tuberculosis Case Definition for Public Health Surveillance1 
  
Tuberculosis (Revised 9/96) 
  
Clinical description 
A chronic bacterial infection caused by Mycobacterium tuberculosis, characterized 
pathologically by the formation of granulomas. The most common site of infection is the lung, 
but other organs may be involved.  
  
Clinical case definition 
A case that meets the following criteria: 
 A positive tuberculin skin test 
 Other signs and symptoms compatible with tuberculosis (e.g., an abnormal, unstable            
[i.e., worsening or improving] chest radiographs, or clinical evidence of current                    
disease) 
 Treatment with two or more antituberculosis medications 
 Completed diagnostic evaluation 
   
Laboratory criteria for diagnosis 
 Isolation of M. tuberculosis from a clinical specimen* or 
 Demonstration of M. tuberculosis from a clinical specimen by nucleic acid                            
amplification test†, or   
 Demonstration of acid-fast bacilli in a clinical specimen when a culture has not been or 
 cannot be obtained.  
   
Case classification 
Confirmed: a case that meets the clinical case definition or is laboratory confirmed 
  
Comment 
A case should not be counted twice within any consecutive 12-month period. However, cases in 
which the patients had previously had verified disease should be reported again if the patients 
were discharged from treatment. Cases also should be reported again if patients were lost to 
supervision for >12 months and disease can be verified again. Mycobacterial diseases other 
than those caused by M. tuberculosis complex should not be counted in tuberculosis morbidity 
statistics unless there is concurrent tuberculosis. 
------------------------------------------------------------------------------------------------------------------ 
1CDC. Case definitions for infectious conditions under public health surveillance.  MMWR   
1997;46(No. RR-10):40-41. 
*Use of rapid identification techniques for M. tuberculosis (e.g., DNA probes and mycolic 
  acids high-pressure liquid chromatography performed on a culture from a clinical specimen) 
  are acceptable under this criterion. 
†Nucleic acid amplification (NAA) tests must be accompanied by culture for mycobacteria 
  species. However, for surveillance purposes, CDC will accept results obtained from NAA 
  tests approved by the Food and Drug Administration (FDA) and used according to the 
  approved product labeling on the package insert. Current FDA-approved NAA tests are only 
  approved for smear-positive respiratory specimens.
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 Appendix C 
 
 
  Recommendations for Counting Reported Tuberculosis Cases  
 (Revised July 1997)  
 
  
Since publication of the “Recommendations for Counting Reported Tuberculosis Cases”1 in 
January 1977, numerous changes have occurred and many issues have been raised within the 
field of tuberculosis (TB) surveillance.  This current version updates and supersedes the previous 
version; it clarifies the parameters for counting TB cases among (a) immigrants, resident aliens, 
and border crossers, (b) military personnel stationed in the United States and abroad, and (c) 
persons diagnosed within the Indian Health Service and correctional facilities. 
  
A distinction should be made between reporting TB cases to a health department and counting 
TB cases for determining incidence of disease.  Throughout each year, TB cases and suspected 
cases are reported to public health authorities by sources such as clinics, hospitals, laboratories, 
and health care providers.  From these reports, the state or local TB control officer must 
determine which cases meet the current surveillance definition for TB disease.  These verified 
TB cases are then counted and reported to the Centers for Disease Control and Prevention 
(CDC). 
  
I.    Reporting TB Cases.—CDC recommends that health care providers and laboratories be 
required to report all TB cases or suspected cases to state and local health departments based on 
the current “Case Definition for Public Health Surveillance.”2 This notification is essential in 
order for TB programs to 
• Ensure case supervision 
  • Ensure completion of appropriate therapy 
• Ensure completion of timely contact investigations 
• Evaluate program effectiveness  
  • Assess trends and characteristics of TB morbidity 
   
II. TB Surveillance.—For purposes of surveillance, a case of TB is defined on the basis of 
laboratory and/or clinical evidence of active disease due to M. tuberculosis complex.* 
  
 
________________________________ 
 
*Mycobacterium tuberculosis complex (M. tuberculosis complex) consists of three 
mycobacterial species: M. tuberculosis, M. bovis, and M. africanum.  These species are identical 
in DNA homology studies.  In terms of their ability to cause clinical disease and be transmissible 
from person to person, M. bovis and M. africanum behave like M. tuberculosis;  therefore, 
disease caused by any of the three organisms should be reported as TB, using the Report of 
Verified Case of Tuberculosis (RVCT).  The only exception is the BCG strain of M. bovis, which 
may be isolated from persons who have received the vaccine for protection against TB or as 
cancer immunotherapy; disease caused by this M. bovis strain should not be reported as TB 
because the transmission is iatrogenic (treatment-induced), rather than person-to-person or 
communicable. 
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a.  Laboratory Case Definition. 
  
! Isolation of M. tuberculosis complex from a clinical specimen.  The use of 
rapid-identification techniques for M. tuberculosis performed on a culture from a clinical 
specimen, such as DNA probes and high-pressure liquid chromatography (HPLC), is 
acceptable under this criterion. 
  
OR 
 
! Demonstration of M. tuberculosis from a clinical specimen by nucleic acid amplification 
(NAA) test.  NAA tests must be accompanied by cultures of mycobacterial species.  
However, for surveillance purposes, CDC will accept results obtained from NAA tests 
that are approved by the Food and Drug  Administration (FDA) and used according to 
the approved product labeling on the package insert.  Current FDA-approved NAA tests 
are only approved for use on smear-positive respiratory specimens. 
                                                 
                                                         OR    
 
! Demonstration of acid-fast bacilli (AFB) in a clinical specimen when a culture has 
  not been or cannot be obtained; historically this criterion has been most 
commonly  used to diagnose TB in the postmortem setting.   
 
b. Clinical Case Definition.—In the absence of laboratory confirmation of M. tuberculosis 
complex after a diagnostic process has been completed, persons must have all of the following 
criteria for clinical TB: 
  
! Evidence of TB infection based on a positive tuberculin skin test 
  
AND  
   
! One of the following: 
1. Signs and symptoms compatible with current TB disease, such as an 
abnormal,unstable (worsening or improving) chest radiograph, or 
2. Clinical evidence of current disease (e.g., fever, night sweats, cough, 
weight loss, hemoptysis) 
  
AND 
 
! Current treatment with two or more anti-TB medications  
  
NOTE: The case definition described herein was developed for use in this document and is not 
intended to replace the case definition for TB as stated in the current “Case Definitions for 
Infectious Conditions Under Public Health Surveillance.” 
  
In addition, the software for TB surveillance developed by CDC includes a calculated variable 
called “Vercrit,” for which one of the values is “Provider Diagnosis.” “Provider Diagnosis”  
 
is selected when the user chooses to override a “Suspect” default value in the case verification 
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screen as “Verified by Provider Diagnosis.” Thus, “Provider Diagnosis” is not a component 
of the case definition for TB in the current “Case Definitions for Infectious Conditions Under 
Public Health Surveillance” publication.  CDC’s national morbidity reports have traditionally 
included all cases that are considered verified by the reporting areas, without a requirement 
that cases meet the published case definition. 
 
III. Counting TB Cases.—Cases that meet the current CDC surveillance case definition 
for verified TB are counted by 52 reporting areas with count authority (50 states, District of 
Columbia, and New York City) to determine annual incidence for the United States.  The 
remaining 7 reporting areas (American Samoa, Federated States of Micronesia, Guam, 
Northern Mariana Islands, Puerto Rico, Republic of Palau, and the U.S. Virgin Islands) report 
cases to the CDC but are not included in the annual incidence for the United States.  
Laboratory and clinical case definitions are the two primary diagnostic categories used by the 
CDC “Case Definitions for Infectious Conditions Under Public Health Surveillance.”  
  
Most verified TB cases are accepted for counting based on laboratory confirmation of M. 
tuberculosis complex from a clinical specimen. 
  
A person may have more than one discrete (separate and distinct) episode of TB.  If disease 
recurs in a person within any 12-consecutive-month period, count only one episode as a case 
for that year.  However, if TB disease recurs in a person, and if more than 12 months have 
elapsed since the person was discharged from or lost to supervision, the TB is considered a 
separate episode and should be counted as a new case. 
  
Mycobacterial diseases other than those caused by M. tuberculosis complex should not be 
counted in TB morbidity statistics unless there is concurrent TB.  
 
a. Verified TB Cases. 
  
COUNT 
Count only verified TB cases that meet the laboratory or clinical case definitions (see 
Section II).  The diagnosis of TB must be verified by the TB control officer or 
designee.  The current CDC surveillance case definition for TB describes and defines 
the criteria to be used in the case definition for TB disease.  
  
DO NOT COUNT 
If diagnostic procedures have not been completed, do not count; wait for confirmation 
of disease.  Do not count a case for which two or more anti-TB medications have been 
prescribed for preventive therapy for exposure to multidrug-resistant (MDR) TB, or 
while the diagnosis is still pending. 
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b. Nontuberculous Mycobacterial Diseases (NTM). 
  
COUNT 
An episode of TB disease diagnosed concurrently with another nontuberculous 
mycobacterial disease should be counted as a TB case. 
  
DO NOT COUNT 
Disease attributed to or caused by nontuberculous mycobacteria alone should not be 
counted as a TB case.  
 
c. TB Cases Reported at Death. 
  
COUNT 
TB cases first reported to the health department at the time of a person’s death are 
counted as incident cases provided that the person had current disease at the time of 
death.  The TB control officer should verify the diagnosis of TB. 
  
DO NOT COUNT 
Do not count as a case of TB if there is no evidence of current disease at the time of 
death or at autopsy. 
  
d. Immigrants, Refugees, Permanent Resident Aliens, Border Crossers,* and Foreign 
Visitors.4 
  
COUNT 
Immigrants and refugees who have been screened overseas for TB and 
! have been classified as Class B (B1, B2, or B3)3 or resident aliens 
! are not already on anti-TB medications for treatment of tuberculous disease, and 
! are examined after arriving in the United States and diagnosed with clinically 
active TB requiring anti-TB medications 
should be counted by the locality of their current residence at the time of diagnosis        
  regardless of citizenship status. 
  
Border crossers* and permanent resident aliens who are diagnosed with TB and plan to 
receive anti-TB therapy from a locality in the United States for 90 days or more should 
be counted by the locality where they receive anti-TB therapy. 
  
Foreign visitors (e.g., students, commercial representatives, and diplomatic personnel) 
who are diagnosed with TB, are receiving anti-TB therapy, and plan to remain in the 
United States for 90 days or more should be counted by the locality of current 
residence. 
  
*Border crosser - defined, in part, by the Immigration and Naturalization Service 
(INS)4  as “a nonresident alien entering the United States across the Mexican border for 
stays of no more than 72 hours.”  Border crossers may go back and forth across the 
border many times in a short period. 
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DO NOT COUNT 
TB cases in immigrants or refugees who have been classified as Class A with a waiver 
(TB, infectious, “Noncommunicable for travel purposes”)3 should not be counted as 
new cases even if the persons receive routine initial work-ups in the United States.   
  
TB in persons who are temporarily (<90 days) in the United States, for whom therapy 
may have been started but who plan to return to their native country to continue 
therapy, should not be counted in the United States. 
 
 e. Out-of-State or Out-of-Area Residents.  
  
COUNT 
A person’s TB case should be counted by the locality in which he or she resides at the 
time of diagnosis.  TB in a person who has no address should be counted by the locality 
that diagnosed and is treating the TB.  The TB control officer should notify the 
appropriate out-of-state or out-of-area TB control officer of the person’s home locality 
to (1) determine whether the case has already been counted to avoid “double counting,” 
and (2) agree on which TB control office should count the case if it has not yet been      
 counted.  
   
DO NOT COUNT  
Do not count a case in a newly diagnosed TB patient who is an out-of-area resident and 
whose TB has already been counted by the out-of-area TB control office. 
 
f. Migrants and Other Transients.  
  
COUNT 
Persons without any fixed U.S. residence are considered to be the public health 
responsibility of their present locality and their TB case should be reported and counted 
where diagnosed. 
  
DO NOT COUNT 
Cases in transient TB patients should not be counted when there is evidence that they 
have already been counted by another locality. 
  
g. Federal Facilities (e.g., Military and Veterans Administration Facilities).    
 
COUNT 
Cases in military personnel, dependents, or veterans should be reported and counted by 
the locality where the persons are residing in the United States at the time of diagnosis 
and initiation of treatment. 
  
However, if military personnel or dependents are discovered to have TB at a military 
base outside the United States but are referred elsewhere for treatment (e.g., a military 
base located within the United States), the TB case should be reported and counted 
where treated and not where the diagnosis was made. 
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  DO NOT COUNT 
Do not count if the case was already counted by another locality in the United States. 
 
h. Indian Health Service. 
  
COUNT 
TB should be reported to the local health authority (e.g., state or county) and counted 
where diagnosed and treatment initiated.  However, for a specific group such as the 
Navajo Nation, which is geographically located in multiple states, health departments 
should discuss each case and determine which locality should count the case. 
  
DO NOT COUNT 
Do not count if the case was already counted by another locality. 
  
i. Correctional Facilities (e.g., Local, State, Federal, and Military). 
  
COUNT 
Persons who reside in local, state, federal, or military correctional facilities may 
frequently be transferred or relocated within and/or between various correctional 
facilities.  TB in these persons should be reported to the local health authority and 
counted by the locality where the diagnosis was made and treatment plans were 
initiated. 
 
DO NOT COUNT 
Do not count correctional facility residents’ TB cases that were counted elsewhere by 
another locality or correctional facility, even if treatment continues at another locale or 
correctional facility. 
  
j. Peace Corps, Missionaries, and Other Citizens Residing Outside the United States. 
  
DO NOT COUNT 
TB in persons diagnosed outside the United States should not be counted.  TB in these 
persons should be counted by the country in which they are residing regardless of their 
plans to return to the United States for further work-up or treatment. 
  
IV. Suggested Administrative Practices.—To promote uniformity in TB case counting, 
the following administrative procedures are recommended: 
  
(a)  All TB cases verified during the calendar year by the 52 reporting areas with count 
authority (50 states, District of Columbia, and New York City) by December 31 will be 
included in the annual U.S. incidence count for that year.  All tuberculosis cases 
verified during the calendar year by a reporting area with count authority from one of 
the remaining 7 reporting areas (American Samoa, Federated States of Micronesia, 
Guam, Northern Mariana Islands, Puerto Rico, Republic of Palau, and the U.S. Virgin 
Islands) are also counted but are not included in the annual incidence for the United 
States.  Cases for which bacteriologic results are pending or for which confirmation of 
disease is questionable for any other reason should not be counted until their status is  
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clearly determined; they should be counted at the time they meet the criteria for 
counting.  This means that a case reported in one calendar year could be included in the 
morbidity count for the following year.  The reporting area with count authority should 
ensure that there is agreement between final local and state TB figures reported to 
CDC.  Currently, some reporting areas may not use this suggested protocol.  Some of 
these areas may wait until the beginning of the following year when they have received 
and processed all of the TB cases for inclusion in the annual case count for the previous 
year.  If reporting areas decide to revise their protocols, they should be aware that TB 
trends may change.   
 
(b)  TB is occasionally reported to health departments over the telephone, by letter or 
fax, or on forms other than the Report of Verified Case of Tuberculosis (RVCT).  Such 
information should be accepted as an official morbidity report if sufficient details are 
provided; otherwise, the notification should be used as an indicator of a possible TB 
case (suspect) which should be investigated promptly for confirmation. 
  
V. TB Surveillance Definitions. 
  
Case - an episode of TB disease in a person meeting the laboratory or clinical criteria 
for TB as defined in the document “Case Definitions for Infectious Conditions Under 
Public Health Surveillance”2 (see Section II for criteria). 
   
Suspect - a person for whom there is a high index of suspicion for active TB (e.g., a 
known contact to an active TB case or a person with signs/symptoms consistent with 
TB) who is currently under evaluation for TB disease. 
 
Verification of a TB case - the process whereby a TB case, after the diagnostic 
evaluation is complete, is reviewed at the local level (e.g., state or county) by a TB 
control official who is familiar with TB surveillance definitions; if all the criteria for a 
TB case are met, the TB case is then verified and eligible for counting.  
  
Counting of a TB case - the process whereby a reporting area with count authority 
evaluates verified TB cases (e.g., assesses for case duplication).  These cases are then 
counted for morbidity in that locality (e.g., state or county) and reported to CDC for 
national morbidity counting. 
  
Mycobacterium tuberculosis complex (M. tuberculosis complex) - consists of three 
mycobacterial species: M. tuberculosis, M. bovis, and M. africanum.  These species are 
identical in DNA homology studies.  In terms of their ability to cause clinical disease 
and to be transmissible from person to person, M. bovis and M. africanum behave like 
M. tuberculosis; therefore, disease caused by any of the three organisms should be 
reported as TB, using the Report of Verified Case of Tuberculosis (RVCT).  The only 
exception is the BCG strain of M. bovis, which may be isolated from persons who have 
received the vaccine to protect against TB or as cancer immunotherapy; disease caused 
by this M. bovis strain should not be reported as TB because the transmission is 
iatrogenic (treatment-induced), rather than person-to-person or communicable. 
   
Nontuberculous mycobacteria (NTM) - mycobacteria other than Mycobacterium 
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tuberculosis complex that can cause human infection or disease.  Common 
nontuberculous mycobacteria include M. avium complex or MAC (M. avium, M. 
intracellulare), M. kansasii, M. marinum, M. scrofulaceum, M. chelonae, M. fortuitum, 
and M. simiae.  Other terms have been used to represent NTM, including MOTT 
(mycobacteria other than TB) and “atypical” mycobacteria. 
  
Reporting area - areas responsible for counting and reporting verified TB cases to 
CDC.  Currently there are 59 reporting areas; 50 states, District of Columbia, New 
York City, American Samoa, Federated States of Micronesia, Guam, Northern Mariana 
Islands, Puerto Rico, Republic of Palau, and the U.S. Virgin Islands.  Annual incidence 
of tuberculosis for the United States is based on 52 reporting areas (50 states, District 
of Columbia, and New York City). 
  
Alien - defined by the Immigration and Naturalization Service (INS)4  as “any person 
not a citizen or national of the United States.” 
  
Border crosser - defined, in part, by the Immigration and Naturalization Service 
(INS)4 as “a nonresident alien entering the United States across the Mexican border for 
stays of no more than 72 hours.”  Border crossers may go back and forth across the 
border many times in a short period. 
 
Class A (TB, Infectious) - defined by the Division of Quarantine3 as an alien “with an 
abnormal chest radiograph or series of chest radiographs suggestive of current 
pulmonary TB and one or more positive sputum smear examinations for acid-fast 
bacilli.” This person is not authorized to enter the United States unless a waiver has 
been granted (see definition for Class A - TB, Infectious, “Noncommunicable for travel 
purposes.”) 
 
Class A (TB, Infectious, “Noncommunicable for travel purposes”) - defined by the 
Division of Quarantine3 as an alien “with an abnormal chest radiograph or series of 
chest radiographs suggestive of active TB, a history of one or more positive sputum 
smear examinations for acid-fast bacilli, currently on recommended treatment, and 
sputum smears that are negative for acid-fast bacilli on 3 consecutive days.” This 
person is authorized to enter the United States if a waiver has been granted. 
  
Class B1 (TB, clinically active, not infectious) - defined by the Division of 
Quarantine3 as an alien “with an abnormal chest radiograph or series of chest 
radiographs suggestive of active TB, and sputum smears that are negative for acid-fast 
bacilli on 3 consecutive days.” This person may be on anti-TB medications when 
entering the United States. 
 
Class B1 (Extrapulmonary TB, clinically active, not infectious) - defined by the 
Division of Quarantine3 as an alien “with radiographic or other evidence of 
extrapulmonary TB, clinically active.” This person may be on anti-TB medications 
when entering the United States.  
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Class B2 (TB, not clinically active) - defined by the Division of Quarantine3 as 
an alien “with an abnormal chest radiograph or series of chest radiographs 
suggestive of active TB, not clinically active (e.g., fibrosis, scarring, pleural 
thickening, diaphragmatic tenting, blunting of costophrenic angles.)  Sputum 
smears are not required.” Such a person who “completed the recommended 
course of anti-TB therapy and whose chest radiographs are stable should be 
reported as Class B2 - TB, treatment completed.” This person may be on anti-TB 
medications when entering the United States. 
  
Class B3 (Consistent with TB, old or healed) - defined by the Division of 
Quarantine3 as an alien “with an abnormal chest radiograph or series of chest 
radiographs (the only abnormality is a calcified lymph node, calcified primary 
complex, or calcified granuloma).  Sputum smears are not required.” 
  
Immigrant - defined by the Immigration and Naturalization Service (INS)4  as 
“an alien admitted to the United States as a lawful permanent resident.  
Immigrants are those persons lawfully accorded the privilege of residing 
permanently in the United States.  They may be issued immigrant visas by the 
Department of State overseas or adjusted to permanent resident status by the 
Immigration and Naturalization Service of the United States.” 
  
Permanent Resident Alien - see Immigrant.  
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